Search:
Tokushima UniversityUniversity HospitalCentral Clinical FacilitiesDepartment of Patient Safety
Tokushima UniversityUniversity HospitalClinical DivisionDepartment of SurgeryDigestive Surgery and Transplantation
Tokushima UniversityResearch ClustersResearch Clusters (Registered)2104008 慢性炎症を介した老化制御および生活習慣病病態の解明と予防法の探索
(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Personal Web Page

Field of Study

Medicine
医学

Subject of Study

消化器外科学,肝胆膵外科,細胞移植,再生医療,安全管理学

Book / Paper

Book:

1. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, 岩橋 衆一 and 斎藤 裕 :
腹腔鏡下肝切除術 4.術中・術後のトラブルと回避法 ガス塞栓,
NANZANDO Co.,Ltd., 2010.

Academic Paper (Judged Full Paper):

1. Shinichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Mayuko Shimizu, Koichi Tsuneyama, Mitsue Nishiyama, Shiori Ishizawa and Mitsuo Shimada :
Effect of daikenchuto (TU-100) on carcinogenesis in non-alcoholic steatohepatitis.,
The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 66-73, 2023.
(Tokushima University Institutional Repository: 118309,   DOI: 10.2152/jmi.70.66,   PubMed: 37164745)
2. Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Katsuki Miyazaki, Mayuko Shimizu, Koichi Tsuneyama and Mitsuo Shimada :
Inhibitory effect of non-alcoholic steatohepatitis on colon cancer liver metastasis.,
EJSO - European Journal of Surgical Oncology, Vol.49, No.2, 410-415, 2022.
(DOI: 10.1016/j.ejso.2022.11.002,   PubMed: 36371329)
3. Shoko Yamashita, Chie Takasu, Yuji Morine, Hiroki Ishibashi, Tetsuya Ikemoto, Hiroki Mori, Shinichiro Yamada, Takeshi Oya, Koichi Tsuneyama and Mitsuo Shimada :
Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation.,
Journal of Hepato-Biliary-Pancreatic Sciences, Vol.30, No.4, 462-472, 2022.
(Tokushima University Institutional Repository: 119056,   DOI: 10.1002/jhbp.1253,   PubMed: 36259178)
4. Katsuki Miyazaki, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita, Takeshi Oya, Tetsuya Ikemoto, Satoru Imura, Haun Hu, Hisayoshi Morioka, Koichi Tsuneyama and Mitsuo Shimada :
Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.,
International Journal of Clinical Oncology, Vol.26, No.12, 2265-2274, 2021.
(DOI: 10.1007/s10147-021-02026-3,   PubMed: 34596803)
5. Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Katsuki Miyazaki, Shin-ichiro Yamada, Satoru Imura, Masato Miyake, Yuji Morine, Seiichi Oyadomari and Mitsuo Shimada :
Effective three-dimensional culture of hepatocyte-like cells generated from human adipose-derived mesenchymal stem cells.,
Journal of Hepato-Biliary-Pancreatic Sciences, Vol.28, No.9, 705-715, 2021.
(DOI: 10.1002/jhbp.1024,   PubMed: 34318615)
6. Shoko Yamashita, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Shinichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Katsuki Miyazaki, Takeshi Oya, Koichi Tsuneyama and Mitsuo Shimada :
A new pathological classification of intrahepatic cholangiocarcinoma according to protein expression of SSTR2 and Bcl2.,
World Journal of Surgical Oncology, Vol.19, No.1, 142, 2021.
(Tokushima University Institutional Repository: 116986,   DOI: 10.1186/s12957-021-02216-3,   PubMed: 33962620)
7. Yusuke Arakawa, Katsuki Miyazaki, Masato Yoshikawa, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Value of the fibrinogen-platelet ratio in patients with resectable pancreatic cancer.,
The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 342-346, 2021.
(Tokushima University Institutional Repository: 116535,   DOI: 10.2152/jmi.68.342,   PubMed: 34759156)
8. Masanori Takehara, Yasushi Sato, Tetsuo Kimura, Kazuyoshi Noda, Hiroshi Miyamoto, Yasuteru Fujino, Jinsei Miyoshi, Fumika Nakamura, Hironori Wada, Yoshimi Bando, Tetsuya Ikemoto, Mitsuo Shimada, Naoki Muguruma and Tetsuji Takayama :
Cancer-associated Adipocytes Promote Pancreatic Cancer Progression Through SAA1 Expression,
Cancer Science, Vol.111, No.8, 2883-2894, 2020.
(Tokushima University Institutional Repository: 115328,   DOI: 10.1111/cas.14527,   PubMed: 32535957,   Elsevier: Scopus)
9. Shuichi Iwahashi, Feng Rui, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.,
Anticancer Research, Vol.40, No.2, 743-749, 2020.
(DOI: 10.21873/anticanres.14005,   PubMed: 32014916)
10. Shuichi Iwahashi, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Toru Utsunomiya :
Effect of epigenetic modulation on cancer sphere.,
The Journal of Medical Investigation : JMI, Vol.67, No.1.2, 70-74, 2020.
(Tokushima University Institutional Repository: 114755,   DOI: 10.2152/jmi.67.70,   PubMed: 32378621)
11. Shogo Ohta, Tetsuya Ikemoto, Yuma Wada, Yu Saitou, Shin-ichiro Yamada, Satoru Imura, Yuji Morine and Mitsuo Shimada :
A change in the zinc ion concentration reflects the maturation of insulin-producing cells generated from adipose-derived mesenchymal stem cells.,
Scientific Reports, Vol.9, No.1, 18731, 2019.
(Tokushima University Institutional Repository: 114940,   DOI: 10.1038/s41598-019-55172-0,   PubMed: 31822724)
12. Tetsuya Ikemoto, Rui Feng, Shuichi Iwahashi, Shin-ichiro Yamada, Yu Saitou, Yuji Morine, Satoru Imura, Munehide Matsuhisa and Mitsuo Shimada :
In vitro and in vivo effects of insulin-producing cells generated by xeno-antigen free 3D culture with RCP piece.,
Scientific Reports, Vol.9, No.1, 2019.
(Tokushima University Institutional Repository: 114941,   DOI: 10.1038/s41598-019-47257-7,   PubMed: 31341242)
13. Akemi Hara, Yuko Nakagawa, Keiko Nakao, Motoyuki Tamaki, Tetsuya Ikemoto, Mitsuo Shimada, Munehide Matsuhisa, Hiroki Mizukami, Nobuhiro Maruyama, Hirotaka Watada and Yoshio Fujitani :
Development of monoclonal mouse antibodies that specifically recognize pancreatic polypeptide.,
Endocrine Journal, Vol.66, No.5, 459-468, 2019.
(Tokushima University Institutional Repository: 118704,   DOI: 10.1507/endocrj.EJ18-0441,   PubMed: 30842364,   Elsevier: Scopus)
14. Rui Feng, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
Photobiomodulation with red light emitting diodes accelerates hepatocytes proliferation through reactive oxygen species / extracellular signal-regulated kinase pathway.,
Hepatology Research, Vol.48, No.11, 926-936, 2018.
(DOI: 10.1111/hepr.13182,   Elsevier: Scopus)
15. Rui Feng, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction,
Cell Communication & Signaling, Vol.16, No.1, 54, 2018.
(Tokushima University Institutional Repository: 114549,   DOI: 10.1186/s12964-018-0262-x,   PubMed: 30180849,   Elsevier: Scopus)
16. Yu Saitou, Satoru Imura, Tetsuya Ikemoto, Yuji Morine, 杉本 真樹 and Mitsuo Shimada :
肝癌手術エキスパートへの道 (特集 癌手術エキスパートになるための道),
Journal of Clinical Surgery, Vol.73, No.9, 1108-1114, 2018.
(CiNii: 1390845702315677568)
17. Yu Saitou, Shin-ichiro Yamada, Shuichi Iwahashi, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
胆道再建を含む肝切除術 (ビギナーズ特集 手術で臓器が「どうなる?」から術後ケアが見える! わかる! イラスト理解 消化器外科の術式・術後ケア),
Gastroenterological Surgery Nursing, Vol.23, No.8, 709-714, 2018.
(CiNii: 1521980703420258944)
18. Rui Feng, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro.,
Cancer Science, Vol.109, No.8, 2509-2519, 2018.
(Tokushima University Institutional Repository: 112899,   DOI: 10.1111/cas.13694,   PubMed: 29902349,   Elsevier: Scopus)
19. Yu Saitou, Shin-ichiro Yamada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shuichi Iwahashi and Mitsuo Shimada :
A learning curve for laparoscopic liver resection: an effective training system and standardization of technique.,
Translational Gastroenterology and Hepatology, Vol.3, 45, 2018.
(DOI: 10.21037/tgh.2018.07.03,   PubMed: 30148230,   Elsevier: Scopus)
20. Youichiro Kawashita, Yuji Morine, Yu Saitou, Chie Takasu, Tetsuya Ikemoto, Shuichi Iwahashi, Hiroki Teraoku, Masato Yoshikawa, Satoru Imura, Toshiyuki Yagi and Mitsuo Shimada :
Role of heat shock factor 1 expression in the microenvironment of intrahepatic cholangiocarcinomas.,
Journal of Gastroenterology and Hepatology, Vol.33, No.7, 1407-1412, 2018.
(DOI: 10.1111/jgh.14078,   PubMed: 29278438,   Elsevier: Scopus)
21. Tetsuya Ikemoto, Rui Feng, Mitsuo Shimada, Yu Saitou, Shuichi Iwahashi, Yuji Morine and Satoru Imura :
A new 2-step acceleration protocol using a histone deacetylase inhibitor to generate insulin-producing cells from adipose-derived mesenchymal stem cells,
Pancreas, Vol.47, No.4, 477-481, 2018.
(DOI: 10.1097/MPA.0000000000001017,   PubMed: 29517636,   Elsevier: Scopus)
22. Satoru Imura, Hiroki Teraoku, Masato Yoshikawa, Daichi Ishikawa, Shin-ichiro Yamada, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.,
International Journal of Clinical Oncology, Vol.23, No.1, 98-103, 2018.
(DOI: 10.1007/s10147-017-1189-8,   PubMed: 28875240,   Elsevier: Scopus)
23. Toshiaki Yoshimoto, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Chie Takasu, Daichi Ishikawa, Hiroki Teraoku, Yoshimi Bando and Mitsuo Shimada :
The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.,
Anticancer Research, Vol.38, No.1, 501-507, 2018.
(DOI: 10.21873/anticanres.12250,   PubMed: 29277815,   Elsevier: Scopus)
24. Tetsuo Kimura, Hiroshi Miyamoto, Akira Fukuya, Shinji Kitamura, Koichi Okamoto, Masako Kimura, Naoki Muguruma, Tetsuya Ikemoto, Mitsuo Shimada, Akiko Yoneda, Yoshimi Bando, Makoto Takishita and Tetsuji Takayama :
Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma.,
Clinical Journal of Gastroenterology, Vol.9, No.4, 261-265, 2016.
(DOI: 10.1007/s12328-016-0655-6,   PubMed: 27262570)
25. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, Mami Kanamoto, Hiroki Ishibashi and Toru Utsunomiya :
Detection of Lymph Nodes Metastasis in Biliary Carcinomas:Morphological Criteria by MDCT and the Clinical Impact of DEI-MRI,
Hepato-Gastroenterology, Vol.62, No.140, 777-781, 2015.
(PubMed: 26901999)
26. Chinbold Enkhbold, Yuji Morine, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shinichiro Yamada, Daichi Ishikawa and Mitsuo Shimada :
Dysfunction of liver regeneration in aged liver after partial hepatectomy.,
Journal of Gastroenterology and Hepatology, Vol.30, No.7, 1217-1224, 2015.
(DOI: 10.1111/jgh.12930,   PubMed: 25682855)
27. Tetsuya Ikemoto, Koji Sugimoto, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou and Shinichiro Yamada :
Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.,
Journal of Gastroenterology and Hepatology, Vol.30, No.1, 217-222, 2015.
(DOI: 10.1111/jgh.12660,   PubMed: 25041344)
28. Michihito Asanoma, Hiroki Mori, Tetsuya Ikemoto, Toru Utsunomiya, Satoru Imura, Yuji Morine, Jun Hanaoka, Mami Kanamoto, Yu Saitou, Shinichiro Yamada and Mitsuo Shimada :
Clinical role of Foxp3+ regulatory T cell in Living donor related liver transplantation for prediction of life-threatening complications.,
The Journal of Medical Investigation : JMI, Vol.62, No.1-2, 37-40, 2015.
(Tokushima University Institutional Repository: 111243,   DOI: 10.2152/jmi.62.37,   PubMed: 25817281,   Elsevier: Scopus)
29. Kayo Hirose, Shinji Kawahito, Naoji Mita, Kazumi Takaishi, Tomiya Kawahara, Tomohiro Soga, Toshiko Katayama, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mitsuo Shimada, Munehide Matsuhisa and Hiroshi Kitahata :
Usefulness of artificial endocrine pancreas during resection of insulinoma.,
The Journal of Medical Investigation : JMI, Vol.61, No.3-4, 421-425, 2014.
(Tokushima University Institutional Repository: 109597,   DOI: 10.2152/jmi.61.421,   PubMed: 25264066,   Elsevier: Scopus)
30. Chengzhan Zhu, Tohru Utsunomiya, Tetsuya Ikemoto, Shinichiro Yamada, Yuji Morine, Satoru Imura, Yusuke Arakawa, Chie Takasu, Daichi Ishikawa, Issei Imoto and Mitsuo Shimada :
Hypomethylation of Long Interspersed Nuclear Element-1 (LINE-1) is Associated with Poor Prognosis via Activation of c-MET in Hepatocellular Carcinoma.,
Annals of Surgical Oncology, Vol.21, No.4, 729-735, 2014.
(Tokushima University Institutional Repository: 109505,   DOI: 10.1245/s10434-014-3874-4,   PubMed: 24992910,   Elsevier: Scopus)
31. Yu Saitou, Hiroki Mori, Chie Takasu, Masato Komatsu, Jun Hanaoka, Shin-ichiro Yamada, 淺野間 理仁, Tetsuya Ikemoto, Satoru Imura, Yuji Morine, Toru Utsunomiya and Mitsuo Shimada :
Beneficial effects of green tea catechin on massive hepatectomy model in rats.,
Journal of Gastroenterology, 2013.
(DOI: 10.1007/s00535-013-0799-9,   PubMed: 23543313,   Elsevier: Scopus)
32. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Koji Sugimoto, Yu Saitou, Shinichiro Yamada and Michihito Asanoma :
Beneficial effects of enteral nutrition containing with hydrolyzed whey peptide on warm ischemia/reperfusion injury in the rat liver.,
Hepatology Research, Vol.44, No.1, 114-121, 2013.
(DOI: 10.1111/hepr.12097,   PubMed: 23578099,   Elsevier: Scopus)
33. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Tetsuya Ikemoto, Mami Kanamoto and Shuichi Iwahashi :
手術手技 前区域枝門脈灌流領域が上右肝静脈を包含する症例に対する,下右肝静脈温存,上右肝静脈とドレナージ領域を含む,
Operation, Vol.66, No.(12), 1741-1745, 2012.
(CiNii: 1523388080475074432)
34. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Jun Hanaoka, Mami Kanamoto, Shuichi Iwahashi, 山田 眞一郎 and 淺野間 理仁 :
肝切除支援ソフトによる術前シミュレーション,術中ナビゲーション,部分肝臓機能解析,
JJSCAS, Vol.14, No.(3), 148-149, 2012.
35. Satoru Imura, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hidenori Miyake and Mitsuo Shimada :
[達人こだわりの手術テクニック] II. 肝胆膵領域 3. 肝癌に対する区域切除,
Operation, Vol.66, No.(10), 1399-1405, 2012.
(CiNii: 1521417755569899520)
36. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura and Tetsuya Ikemoto :
「内視鏡外科医のための微細局所解剖アトラス」肝胆膵 肝外側区域切除-脈管処理のコツ,
手術.2012, Vol.66, No.(6), 753-759, 2012.
37. Toru Utsunomiya, Mitsuo Shimada, Jun Hanaoka, Mami Kanamoto, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Masafumi Harada :
Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve,
Journal of Gastroenterology, Vol.47, No.4, 470-476, 2012.
(DOI: 10.1007/s00535-011-0513-8,   PubMed: 22170416,   Elsevier: Scopus)
38. Tetsuya Ikemoto and Mitsuo Shimada :
II-4 抗癌剤 「肝胆膵」,
消化器外科レビュー, Vol.2012, 216-221, 2012.
39. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou and Hidenori Miyake :
【内視鏡外科手術をめぐる最近のトピックス】 新たな領域への手術適応 保険収載後の腹腔鏡下肝切除術の展開,
Gastroenterological Surgery, Vol.34, No.1, 69-77, 2011.
40. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine and Tetsuya Ikemoto :
薬物治療学の進歩-この30年-,IX. 肝移植 1)ネオーラル(ノバルティス),
KAN TAN SUI, Vol.61, No.6, 1170-1176, 2010.
41. Tetsuya Ikemoto, Hirofumi Noguchi, Yasutaka Fujita, Morihito Takita, Masayuki Shimoda, Koji Sugimoto, Andrew Jackson, Bashoo Naziruddin, Mitsuo Shimada, Marlon F. Levy and Shinichi Matsumoto :
New stepwise cooling system for short-term porcine islet preservation.,
Pancreas, Vol.39, No.7, 960-963, 2010.
(DOI: 10.1097/MPA.0b013e3181dab19a,   PubMed: 20467350)
42. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, 岩橋 衆一, 川田 祐子 and 斎藤 裕 :
問題を有するドナーからの生体肝移植 ∼胃癌術後ドナーおよび喘息罹患ドナー∼.,
The Japanese journal of clinical and experimental medicine, Vol.87, No.9, 1282-1283, 2010.
43. Hiroki Mori, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Jun Hanaoka :
急性肝不全に対する肝移植術施行のタイミングに難渋した症例,
The Japanese journal of clinical and experimental medicine, Vol.87, No.9, 118-119, 2010.
44. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, Yu Saito, Hisami Okumura and Eiji Takeda :
Impact of splenectomy in patients with liver cirrhosis: Results from 18 patients in a single center experience.,
Hepatology Research, Vol.40, No.9, 894-900, 2010.
(DOI: 10.1111/j.1872-034X.2010.00688.x,   PubMed: 20887594)
45. Tetsuya Ikemoto, Shinichi Matsumoto, Takeshi Itoh, Hirofumi Noguchi, Yoshiko Tamura, Andrew M. Jackson, Masayuki Shimoda, Bashoo Naziruddin, Nicholas Onaca, Yohichi Yasunami and Marlon F. Levy :
Assessment of islet quality following international shipping of more than 10,000 km.,
Cell Transplantation, Vol.19, No.6, 731-741, 2010.
(DOI: 10.3727/096368910X508834,   PubMed: 20525435)
46. Takashi Iwata, Tetsuya Ikemoto, Nobuhiro Kurita, Masanori Nishioka, Toru Utsunomiya and Mitsuo Shimada :
手術機器の使い方-基本と応用- 鏡視下手術用機器 5.リトラクター,
Operation, Vol.64, No.6, 839-844, 2010.
(CiNii: 1522825128351606400)
47. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura and Tetsuya Ikemoto :
特集/必読 最新の肝切除—その2 2.Liver hanging maneuver,
Surgery, Vol.72, No.5, 461-465, 2010.
(CiNii: 1390001288081381504)
48. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, 岩橋 衆一 and 斎藤 裕 :
性差による肝胆膵疾患の臨床,病態,治療効果のDiscrepancy I.性差と各種肝疾患 7)肝移植と性差,
KAN TAN SUI, Vol.60, No.5, 793-799, 2010.
49. Mitsuo Shimada, Koji Sugimoto, Shuichi Iwahashi, Toru Utsunomiya, Yuji Morine, Satoru Imura and Tetsuya Ikemoto :
CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.,
Journal of Gastroenterology, Vol.45, No.8, 896-902, 2010.
(DOI: 10.1007/s00535-010-0235-3,   PubMed: 20379837)
50. Hirofumi Noguchi, Bashoo Naziruddin, Andrew Jackson, Masayuki Shimoda, Tetsuya Ikemoto, Yasutaka Fujita, Daisuke Chujo, Morihito Takita, Naoya Kobayashi, Nicholas Onaca, Marlon F. Levy and Shinichi Matsumoto :
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation.,
Transplantation, Vol.89, No.1, 47-54, 2010.
(DOI: 10.1097/TP.0b013e3181be3bf2,   PubMed: 20061918)
51. Shinya Morimoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori and Jun Hanaoka :
肝癌ステージングと予後推定.,
臨床消化器内科, Vol.25, No.4, 399-494, 2010.
52. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, 金本 真美, 岩橋 衆一 and 斎藤 裕 :
肝移植の画像診断ー生体ドナーの安全とレシピエントの予後向上をめざしてー,
肝胆膵画像, Vol.2, No.1, 69-78, 2010.
53. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shinya Morimoto and Hiroki Mori :
メタボリックシンドロームと肝細胞癌,
G.I.Research, Vol.18, No.3, 224-230, 2010.
54. Satoru Imura, Jun Hanaoka, Hiroki Mori, Tetsuya Ikemoto, Yuji Morine, Toru Utsunomiya, Hidenori Miyake and Mitsuo Shimada :
腹腔鏡下肝切除:腹腔鏡下肝切除術における最近の話題 ∼気腹とガス塞栓∼.,
消化器外科, Vol.33, No.9, 1439-1444, 2010.
55. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine and Tetsuya Ikemoto :
肝・胆道系症候群(Ⅱ)— その他の肝・胆道系疾患を含めて - 肝臓編(下)第2版 XIV 肝細胞癌以外の肝腫瘍 「原発性肝肉腫(Primary hepatic sarcoma)」,
日本臨床2010, 276-280, 2010.
56. Tetsuya Ikemoto, Mitsuo Shimada, Shuichi Iwahashi, 川田 祐子, Yu Saitou, Jun Hanaoka, Hiroki Mori, Satoru Imura, Yuji Morine and Toru Utsunomiya :
乳癌が併存するレシピエント,高度脂肪肝ドナーという組み合わせに施行した生体肝移植.,
The Japanese journal of clinical and experimental medicine, Vol.87, No.9, 1280-1281, 2010.
57. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Hiroki Mori :
血液型不適合肝移植後interferon治療に難渋したC型肝炎の1例,
The Japanese journal of clinical and experimental medicine, Vol.87, No.9, 1330-1331, 2010.

Academic Paper (Unrefereed Paper):

1. Shuhai Chen, Yu Saitou, Yuhei Waki, Tetsuya Ikemoto, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
Generation of Highly Functional Hepatocyte-like Organoids from Human Adipose-Derived Mesenchymal Stem Cells Cultured with Endothelial Cells.,
Cells, Vol.13, No.6, 2024.
(DOI: 10.3390/cells13060547,   PubMed: 38534391)
2. Yuhei Waki, Yuji Morine, Takayuki Noma, Chie Takasu, Hiroki Teraoku, Shinichiro Yamada, Yu Saitou, Tetsuya Ikemoto and Mitsuo Shimada :
Association between high expression of intratumoral fibroblast activation protein and survival in patients with intrahepatic cholangiocarcinoma.,
BMC gastroenterology, Vol.23, No.1, 415, 2023.
(DOI: 10.1186/s12876-023-03012-x,   PubMed: 38017374)
3. Yuhei Waki, Yu Saitou, Shuhai Chen, Tetsuya Ikemoto, Takayuki Noma, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
Effects of green light-emitting diode irradiation on hepatic differentiation of hepatocyte-like cells generated from human adipose-derived mesenchymal cells.,
Scientific reports, Vol.13, No.1, 19954, 2023.
(DOI: 10.1038/s41598-023-45967-7,   PubMed: 37968291)
4. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shinichiro Yamada, Hiroki Teraoku, Sonoko Yasui-Yamada, Maki Nishi, Hiroshi Sakaue, Motomu Kamada, Tetsuya Matsuura and Mitsuo Shimada :
Preoperative Weight Loss Program for Hepatocellular Carcinoma Patients with High Body Mass Index in Hepatectomy.,
World journal of surgery, Vol.47, No.12, 3348-3355, 2023.
(DOI: 10.1007/s00268-023-07220-0,   PubMed: 37840060)
5. 仲須 千春, Shin-ichiro Yamada, Hiroki Teraoku, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
原因が不明であった肝palisading granulomaの1例,
Acta Hepatologica Japonica, Vol.64, No.10, 504-509, 2023.
(DOI: 10.2957/kanzo.64.504)
6. Kozo Yoshikawa, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Shoichiro Takao :
Clinical impact of myosteatosis measured by magnetic resonance imaging on long-term outcomes of hepatocellular carcinoma after radical hepatectomy.,
BMC surgery, Vol.23, No.1, 281, 2023.
(DOI: 10.1186/s12893-023-02188-z,   PubMed: 37715229)
7. Shuhai Chen, Yuji Morine, Yu Saitou, Shinichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
TU-100 Antagonizes the M2 Polarization Phenotype of Macrophages in the Tumor Microenvironment by Suppressing the TLR4/NF-B/STAT3 Axis.,
Anticancer research, Vol.43, No.5, 1985-1992, 2023.
(DOI: 10.21873/anticanres.16359,   PubMed: 37097685)
8. Takayuki Noma, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
術前に肝細胞癌との鑑別が困難であった筋腫型肝血管筋脂肪腫の1例,
Acta Hepatologica Japonica, Vol.64, No.4, 201-208, 2023.
(DOI: 10.2957/kanzo.64.201)
9. Katsuki Miyazaki, Yuji Morine, Caiming Xu, Chiharu Nakasu, Yuuma Wada, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Mitsuo Shimada and Ajay Goel :
Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma.,
Cells, Vol.12, No.4, 2023.
(Tokushima University Institutional Repository: 118580,   DOI: 10.3390/cells12040612,   PubMed: 36831279)
10. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Yuhei Waki, Takayuki Noma, Tetsuya Ikemoto and Mitsuo Shimada :
Multiplication of tumor maximum diameter and number as a new surgical indicator for Barcelona Clinic Liver Cancer intermediate-stage hepatocellular carcinoma.,
Hepatology Research, 2023.
(DOI: 10.1111/hepr.13887,   PubMed: 36755370)
11. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Yuhei Waki, Chiharu Nakasu and Mitsuo Shimada :
Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study.,
BMC surgery, Vol.23, No.1, 6, 2023.
(DOI: 10.1186/s12893-022-01892-6,   PubMed: 36631851)
12. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Yuhei Waki, Chiharu Nakasu and Mitsuo Shimada :
Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study.,
BMC Surgery, Vol.23, No.1, 6, 2023.
(Tokushima University Institutional Repository: 118558,   DOI: 10.1186/s12893-022-01892-6,   PubMed: 36631851)
13. Katsuki Miyazaki, Yuuma Wada, Keisuke Okuno, Tatsuro Murano, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroaki Ikematsu, Yusuke Kinugasa, Mitsuo Shimada and Ajay Goel :
An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer.,
Molecular Cancer, Vol.22, No.1, 2, 2023.
(Tokushima University Institutional Repository: 118926,   DOI: 10.1186/s12943-022-01685-8,   PubMed: 36609320)
14. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
Fontan associated liver disease(FALD)関連肝癌に対しての腹腔鏡肝切除の1例 Fontan循環における肝離断対策,
Acta Hepatologica Japonica, Vol.64, No.1, 18-25, 2023.
(DOI: 10.2957/kanzo.64.18)
15. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shinichiro Yamada, Yuhei Waki, Shohei Okikawa, Katsuki Miyazaki, Chiharu Nakasu, Takayuki Noma, Akira Takahashi and Mitsuo Shimada :
Impact of pancreatic resection in patients with liver cirrhosis.,
The journal of medical investigation : JMI, Vol.70, No.1.2, 189-194, 2023.
(DOI: 10.2152/jmi.70.189,   PubMed: 37164719)
16. Baasansuren Selenge, Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Hiroki Teraoku, Shohei Okikawa and Mitsuo Shimada :
Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma.,
The journal of medical investigation : JMI, Vol.70, No.1.2, 160-165, 2023.
(DOI: 10.2152/jmi.70.160,   PubMed: 37164714)
17. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shinichiro Yamada, Shohei Okikawa, Katsuki Miyazaki and Mitsuo Shimada :
Short- and long-term outcomes of pancreatectomy in patients with hemodialysis.,
The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 105-109, 2023.
(DOI: 10.2152/jmi.70.105,   PubMed: 37164704)
18. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
【胆膵疾患と最新テクノロジーの融合】胆膵疾患における最新の術前術中手術支援システム,
Journal of Biliary Tract & Pancreas, Vol.43, No.12, 1631-1636, 2022.
19. Yuji Morine, Tohru Utsunomiya, Hisami Yamanaka-Okumura, Yu Saitou, Shin-ichiro Yamada, Tetsuya Ikemoto, Satoru Imura, Shohei Kinoshita, Akiyoshi Hirayama, Yasuhito Tanaka and Mitsuo Shimada :
Essential amino acids as diagnostic biomarkers of hepatocellular carcinoma based on metabolic analysis.,
Oncotarget, Vol.13, 1286-1298, 2022.
(DOI: 10.18632/oncotarget.28306,   PubMed: 36441784)
20. Baasansvren Selenge, Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Hiroki Teraoku and Mitsuo Shimada :
Impact of L-type amino acid transporter 3 on the prognosis of hepatocellular carcinoma.,
Oncology Letters, Vol.24, No.5, 418, 2022.
(Tokushima University Institutional Repository: 118271,   DOI: 10.3892/ol.2022.13538,   PubMed: 36245821)
21. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada and Mitsuo Shimada :
A Hepatectomy Based on a Hybrid Concept of Portal Perfusion of Anterior Segment and Venous Drainage Area of Superior Right Hepatic Vein.,
The American Surgeon, 3134820984872, 2022.
(DOI: 10.1177/0003134820984872,   PubMed: 33382339)
22. Yu Saitou, Maki Sugimoto, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada and Mitsuo Shimada :
Intraoperative support with three-dimensional holographic cholangiography in hepatobiliary surgery.,
Langenbeck's Archives of Surgery / Deutsche Gesellschaft für Chirurgie, Vol.407, No.3, 1285-1289, 2022.
(DOI: 10.1007/s00423-021-02336-0,   PubMed: 34557939)
23. Tetsuya Ikemoto and Mitsuo Shimada :
【1型糖尿病-診療と研究の最前線】治療研究 膵β細胞再生医療の可能性 脂肪由来幹細胞の有用性,
Journal of Clinical and Experimental Medicine, Vol.281, No.6, 729-734, 2022.
24. Kazunori Tokuda, Tetsuya Ikemoto, Shoko Yamashita, Katsuki Miyazaki, Shohei Okikawa, Shin-ichiro Yamada, Yu Saitou, Yuji Morine and Mitsuo Shimada :
Syngeneically transplanted insulin producing cells differentiated from adipose derived stem cells undergo delayed damage by autoimmune responses in NOD mice.,
Scientific Reports, Vol.12, No.1, 5852, 2022.
(DOI: 10.1038/s41598-022-09838-x,   PubMed: 35393479)
25. Shohei Okikawa, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Hiroki Teraoku, Katsuki Miyazaki, Shoko Yamashita, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer.,
Oncology Reports, Vol.47, No.4, 2022.
(DOI: 10.3892/or.2022.8282,   PubMed: 35169858)
26. Yuuma Wada, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hideo Baba, Masaki Mori and Ajay Goel :
A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma.,
British Journal of Cancer, Vol.126, No.8, 1196-1204, 2022.
(DOI: 10.1038/s41416-022-01710-z,   PubMed: 35079106)
27. Yuuma Wada, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hideo Baba, Masaki Mori and Ajay Goel :
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases.,
European Journal of Cancer, Vol.163, 66-76, 2022.
(DOI: 10.1016/j.ejca.2021.12.013,   PubMed: 35042069)
28. Shuhai Chen, Tetsuya Ikemoto, Takuya Tokunaga, Shohei Okikawa, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Yuji Morine and Mitsuo Shimada :
Newly Generated 3D Schwann-Like Cell Spheroids From Human Adipose-Derived Stem Cells Using a Modified Protocol.,
Cell Transplantation, Vol.31, 9636897221093312, 2022.
(Tokushima University Institutional Repository: 117435,   DOI: 10.1177/09636897221093312,   PubMed: 35469470)
29. Yuuma Wada, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Zhongxu Zhu, Xin Wang, Ane Etxart, Yangsoon Park, Luis Bujanda, In Ja Park and Ajay Goel :
Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.,
JCO Precision Oncology, Vol.5, 2021.
(DOI: 10.1200/PO.21.00015,   PubMed: 34913022)
30. Luping Gao, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Chie Takasu, Katsuki Miyazaki and Mitsuo Shimada :
Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.,
PLoS ONE, Vol.16, No.9, e0256755, 2021.
(Tokushima University Institutional Repository: 117382,   DOI: 10.1371/journal.pone.0256755,   PubMed: 34473785)
31. Kazunori Tokuda, Yuji Morine, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Masaaki Nishi, Tetsuya Ikemoto and Mitsuo Shimada :
Frailty Can Predict Prognosis After Hepatectomy in Patients With Colorectal Liver Metastasis.,
Anticancer Research, Vol.41, No.9, 4637-4644, 2021.
(DOI: 10.21873/anticanres.15277,   PubMed: 34475092)
32. Luping Gao, Yuji Morine, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Katsuki Miyazaki, Shouhei Okikawa, Chie Takasu and Mitsuo Shimada :
The BAFF/NF B axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.,
Cancer Science, Vol.112, No.9, 3545-3554, 2021.
(Tokushima University Institutional Repository: 116388,   DOI: 10.1111/cas.15041,   PubMed: 34159680)
33. Shuhai Chen, Yuji Morine, Kazunori Tokuda, Shin-ichiro Yamada, Yu Saitou, Masaaki Nishi, Tetsuya Ikemoto and Mitsuo Shimada :
Cancerssociated fibroblastnduced M2olarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor 1 pathway.,
International Journal of Oncology, Vol.59, No.2, 59, 2021.
(Tokushima University Institutional Repository: 117319,   DOI: 10.3892/ijo.2021.5239,   PubMed: 34195849)
34. Satoru Imura, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Utility of cone unit liver resection for small hepatocellular carcinoma: a propensity score matched analysis.,
HPB, Vol.23, No.5, 739-745, 2021.
(DOI: 10.1016/j.hpb.2020.09.010,   PubMed: 32988753)
35. Katsuki Miyazaki, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita, Takeshi Oya, Koichi Tsuneyama and Mitsuo Shimada :
Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8 tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocarcinoma.,
Surgery Today, Vol.51, No.12, 1985-1995, 2021.
(DOI: 10.1007/s00595-021-02295-5,   PubMed: 34009433)
36. Yuuma Wada, Mitsuo Shimada, Tatsuro Murano, Hiroyuki Takamaru, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Francesc Balaguer, Luis Bujanda, Maria Pellise, Ken Kato, Yutaka Saito, Hiroaki Ikematsu and Ajay Goel :
A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.,
Gastroenterology, Vol.161, No.1, 151-162.e1, 2021.
(DOI: 10.1053/j.gastro.2021.03.062,   PubMed: 33819484)
37. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Katsuki Miyazaki, Takuya Tokunaga and Masaaki Nishi :
Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma.,
World Journal of Surgical Oncology, Vol.19, No.1, 94, 2021.
(Tokushima University Institutional Repository: 116675,   DOI: 10.1186/s12957-021-02205-6,   PubMed: 33781262)
38. Yuuma Wada, Mitsuo Shimada, Kensuke Yamamura, Takeo Toshima, Jasjit K. Banwait, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hideo Baba, Masaki Morishima and Ajay Goel :
A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma.,
Hepatology, Vol.74, No.3, 1371-1383, 2021.
(DOI: 10.1002/hep.31803,   PubMed: 33725402)
39. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada and Mitsuo Shimada :
【肝胆膵外科における再切除と再手術-最新の治療戦略】肝細胞癌切除後再発に対する再肝切除 適応と治療成績,
Operation, Vol.75, No.3, 249-256, 2021.
(DOI: 10.18888/op.0000002091)
40. Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Current status of hepatocyte-like cell therapy from stem cells.,
Surgery Today, Vol.51, No.3, 340-349, 2021.
(DOI: 10.1007/s00595-020-02092-6,   PubMed: 32754843)
41. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada and Mitsuo Shimada :
Preoperative prognostic nutritional index predicts short- and long-term outcomes after liver resection in patients with hepatocellular carcinoma.,
Oncology Letters, Vol.21, No.2, 153, 2021.
(DOI: 10.3892/ol.2020.12414,   PubMed: 33552271,   Elsevier: Scopus)
42. Kazunori Tokuda, Yuji Morine, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Masaaki Nishi, Takuya Tokunaga, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma.,
Oncotarget, Vol.12, No.4, 333-343, 2021.
(Tokushima University Institutional Repository: 116612,   DOI: 10.18632/oncotarget.27881,   PubMed: 33659044)
43. Shoko Yamashita, Masaaki Nishi, Tetsuya Ikemoto, Kouzou Yoshikawa, Jun Higashijima, Takuya Tokunaga, Chie Takasu, Hideya Kashihara, Shohei Eto, Toshiaki Yoshimoto and Mitsuo Shimada :
Clinical analysis of postoperative venous thromboembolism in Japanese patients after colorectal cancer surgery.,
Surgery Today, Vol.51, No.6, 1022-1027, 2021.
(DOI: 10.1007/s00595-020-02201-5,   PubMed: 33387025)
44. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa and Katsuki Miyazaki :
Significance of Frailty in Prognosis After Hepatectomy for Elderly Patients with Hepatocellular Carcinoma.,
Annals of Surgical Oncology, Vol.28, No.1, 439-446, 2021.
(DOI: 10.1245/s10434-020-08742-w,   PubMed: 32562115)
45. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada and Mitsuo Shimada :
Regeneration of caudate lobe after living donor liver transplantation : Comparison with a surrogate model of left lobe graft.,
The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 330-333, 2021.
(Tokushima University Institutional Repository: 116533,   DOI: 10.2152/jmi.68.330,   PubMed: 34759154)
46. Yusuke Arakawa, Katsuki Miyazaki, Masato Yoshikawa, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Value of the CRP-albumin ratio in patients with resectable pancreatic cancer.,
The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 244-255, 2021.
(Tokushima University Institutional Repository: 116489,   DOI: 10.2152/jmi.68.244,   PubMed: 34759138)
47. Shuhai Chen, Tetsuya Ikemoto, Takuya Tokunaga, Shohei Okikawa, Katsuki Miyazaki, Kazunori Tokuda, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Effective in vitro differentiation of adipose-derived stem cells into Schwann-like cells with folic acid supplementation.,
The Journal of Medical Investigation : JMI, Vol.68, No.3.4, 347-353, 2021.
(Tokushima University Institutional Repository: 116542,   DOI: 10.2152/jmi.68.347,   PubMed: 34759157)
48. Yuji Morine, Toru Utsunomiya, Yu Saitou, Shin-ichiro Yamada, Satoru Imura, Tetsuya Ikemoto, Akihiro Kitagawa, Yuta Kobayashi, Seiichiro Takao, Keisuke Kosai, Koshi Mimori, Yasuhito Tanaka and Mitsuo Shimada :
Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma.,
Oncotarget, Vol.11, No.52, 4803-4812, 2020.
(Tokushima University Institutional Repository: 116613,   DOI: 10.18632/oncotarget.27852,   PubMed: 33447348)
49. Yuuma Wada, Kazunori Tokuda, Yuji Morine, Shohei Okikawa, Shoko Yamashita, Tetsuya Ikemoto, Satoru Imura, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment.,
Oncotarget, Vol.11, No.49, 4593-4604, 2020.
(Tokushima University Institutional Repository: 116616,   DOI: 10.18632/oncotarget.27835,   PubMed: 33346211)
50. Tetsuya Ikemoto, Kazunori Tokuda, Yuuma Wada, Luping Gao, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Adipose Tissue From Type 1 Diabetes Mellitus Patients Can Be Used to Generate Insulin-Producing Cells.,
Pancreas, Vol.49, No.9, 1225-1231, 2020.
(DOI: 10.1097/MPA.0000000000001663,   PubMed: 32898009)
51. Yuuma Wada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Shin-ichiro Yamada and Mitsuo Shimada :
HIF-1 expression in liver metastasis but not primary colorectal cancer is associated with prognosis of patients with colorectal liver metastasis.,
World Journal of Surgical Oncology, Vol.18, No.1, 241, 2020.
(Tokushima University Institutional Repository: 116676,   DOI: 10.1186/s12957-020-02012-5,   PubMed: 32895059)
52. Kazunori Tokuda, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.,
International Journal of Clinical Oncology, Vol.25, No.12, 2083-2089, 2020.
(DOI: 10.1007/s10147-020-01775-x,   PubMed: 32869120)
53. Shuichi Iwahashi, AHMAD AMMAR GHAIBEH, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou and Jun Hirose :
Predictability of postoperative recurrence on hepatocellular carcinoma through data mining method.,
Molecular and Clinical Oncology, Vol.13, No.5, 46, 2020.
(DOI: 10.3892/mco.2020.2116,   PubMed: 32874576)
54. Toshiaki Yoshimoto, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yu Saitou, Shin-ichiro Yamada, Katsuki Miyazaki, Yukako Takehara and Mitsuo Shimada :
Impact of using a perioperative artificial endocrine pancreas in pancreatic resection.,
Annals of Gastroenterological Surgery, Vol.4, No.5, 591-596, 2020.
(Tokushima University Institutional Repository: 116476,   DOI: 10.1002/ags3.12374,   PubMed: 33005854)
55. Hiroki Teraoku, Yuji Morine, Naoto Uyama, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Chie Takasu, Satoru Imura, Masafumi Harada and Mitsuo Shimada :
Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma.,
World Journal of Surgery, Vol.44, No.7, 2350-2358, 2020.
(DOI: 10.1007/s00268-020-05456-8,   PubMed: 32152739)
56. Katsuki Miyazaki, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
Pancreatoduodenectomy co-morbid with celiac axis compression syndrome: a report of three cases.,
Surgical Case Reports, Vol.6, No.1, 113, 2020.
(DOI: 10.1186/s40792-020-00878-x,   PubMed: 32449014)
57. Shin-ichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa, Katsuki Miyazaki and Mitsuo Shimada :
Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.,
Journal of Hepato-Biliary-Pancreatic Sciences, Vol.27, No.7, 388-395, 2020.
(DOI: 10.1002/jhbp.732,   PubMed: 32162483)
58. Yu Saitou, Maki Sugimoto, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shuichi Iwahashi, Shin-ichiro Yamada and Mitsuo Shimada :
Intraoperative 3D Hologram Support With Mixed Reality Techniques in Liver Surgery.,
Annals of Surgery, Vol.271, No.1, e4-e7, 2020.
(Tokushima University Institutional Repository: 114184,   DOI: 10.1097/SLA.0000000000003552,   PubMed: 31425293)
59. Kazunori Tokuda, Tetsuya Ikemoto, Yu Saitou, Katsuki Miyazaki, Shoko Yamashita, Shin-ichiro Yamada, Satoru Imura, Yuji Morine and Mitsuo Shimada :
The Fragility of Cryopreserved Insulin-producing Cells Differentiated from Adipose-tissue-derived Stem Cells.,
Cell Transplantation, Vol.29, 963689720954798, 2020.
(Tokushima University Institutional Repository: 116513,   DOI: 10.1177/0963689720954798,   PubMed: 32878465)
60. Shogo Oota, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, Yuuma Wada, Shoko Iwahashi, Yoshimi Bando and Mitsuo Shimada :
Carbohydrate Antigen 19-9 Is a Prognostic Factor Which Correlates With HDAC1 and HIF-1 for Intrahepatic Cholangiocarcinoma.,
Anticancer Research, Vol.39, No.11, 6025-6033, 2019.
(DOI: 10.21873/anticanres.13808,   PubMed: 31704828)
61. Yuuma Wada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
The Differences in the Characteristics of Insulin-producing Cells Using Human Adipose-tissue Derived Mesenchymal Stem Cells from Subcutaneous and Visceral Tissues.,
Scientific Reports, Vol.9, No.1, 13204, 2019.
(Tokushima University Institutional Repository: 114942,   DOI: 10.1038/s41598-019-49701-0,   PubMed: 31519950)
62. Hiroki Mori, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Impact of Bevacizumab on Liver Damage After Massive Hepatectomy in Rats.,
In Vivo, Vol.33, No.5, 1469-1476, 2019.
(DOI: 10.21873/invivo.11626,   PubMed: 31471394)
63. Yuji Morine, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, Chie Takasu, Jun Higashijima, Satoru Imura and Mitsuo Shimada :
Clinical Impact of FOLFOXIRI Aiming for Conversion Surgery in Unresectable Multiple Colorectal Liver Metastasis.,
Anticancer Research, Vol.39, No.9, 5089-5096, 2019.
(DOI: 10.21873/anticanres.13703,   PubMed: 31519620)
64. Shoko Iwahashi, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, Toshiaki Yoshimoto, Koichi Tsuneyama and Mitsuo Shimada :
Two cases of non-mucinous cystadenomas of the pancreas with pancreatobiliary phenotype and ovarian-like stroma.,
Surgical Case Reports, Vol.5, No.1, 117, 2019.
(DOI: 10.1186/s40792-019-0673-y,   PubMed: 31338648)
65. Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Kouzou Yoshikawa and Chie Takasu :
免疫チェックポイント時代における漢方とがん免疫,
Kampo Medicine, Vol.70, No.2, 162-166, 2019.
(DOI: 10.3937/kampomed.70.162,   CiNii: 1390002184855144320)
66. Yuuma Wada, Atsushi Takata, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathway.,
Surgery Today, Vol.49, No.6, 536-545, 2019.
(Tokushima University Institutional Repository: 114154,   DOI: 10.1007/s00595-019-1761-0,   PubMed: 30730004)
67. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Masato Yoshikawa, Hiroki Teraoku and Toshiaki Yoshimoto :
A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging.,
PLoS ONE, Vol.14, No.1, e0210579, 2019.
(Tokushima University Institutional Repository: 113041,   DOI: 10.1371/journal.pone.0210579,   PubMed: 30682046)
68. Yu Saitou, Yuji Morine, Shuichi Iwahashi, Tetsuya Ikemoto, Satoru Imura, Hisami Yamanaka-Okumura, Akiyoshi Hirayama, Tomoyoshi Soga, Masaru Tomita and Mitsuo Shimada :
Changes of liver metabolites following hepatectomy with ischemia reperfusion towards liver regeneration.,
Annals of Gastroenterological Surgery, Vol.2, No.3, 204-211, 2018.
(DOI: 10.1002/ags3.12058,   PubMed: 29863192)
69. Toshiaki Yoshimoto, Yuji Morine, Chie Takasu, Rui Feng, Tetsuya Ikemoto, Kouzou Yoshikawa, Shuichi Iwahashi, Yu Saitou, Hideya Kashihara, Masatake Akutagawa, Takahiro Emoto, Yosuke Kinouchi and Mitsuo Shimada :
Blue light-emitting diodes induce autophagy in colon cancer cells by Opsin 3.,
Annals of Gastroenterological Surgery, Vol.2, No.2, 154-161, 2018.
(Tokushima University Institutional Repository: 113689,   DOI: 10.1002/ags3.12055,   PubMed: 29863164)
70. Toshiaki Yoshimoto, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, Daichi Ishikawa, Hiroki Teraoku, Masato Yoshikawa, Jun Higashijima, Chie Takasu and Mitsuo Shimada :
Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.,
In Vivo, Vol.31, No.3, 419-423, 2017.
(DOI: 10.21873/invivo.11076,   PubMed: 28438872)
71. Masato Yoshikawa, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Jun Higashijima, Shuichi Iwahashi, Yu Saitou, Chie Takasu, Shin-ichiro Yamada, Daichi Ishikawa, Hiroki Teraoku, Atsushi Takata, Toshiaki Yoshimoto and Mitsuo Shimada :
Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.,
Anticancer Research, Vol.37, No.3, 1169-1175, 2017.
(Tokushima University Institutional Repository: 112034,   DOI: 10.21873/anticanres.11430,   PubMed: 28314278)
72. M Davaadorj, Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Satoru Imura, Chie Takasu, Shin-ichiro Yamada, Hiroki Teraoku, Masato Yoshikawa and Mitsuo Shimada :
Loss of Secreted Frizzled-Related Protein-1 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.,
EJSO - European Journal of Surgical Oncology, Vol.43, No.2, 344-350, 2017.
(Tokushima University Institutional Repository: 110034,   DOI: 10.1016/j.ejso.2016.11.017,   PubMed: 28062160)
73. Daichi Ishikawa, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, Shinichiro Yamada and Hidenori Miyake :
Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas.,
Journal of Gastroenterology and Hepatology, Vol.29, No.12, 2032-2037, 2014.
(Tokushima University Institutional Repository: 106298,   DOI: 10.1111/jgh.12652,   PubMed: 24909638)
74. Gizachew Yismaw Wubetu, Tohru Utsunomiya, Daichi Ishikawa, Tetsuya Ikemoto, Shinichiro Yamada, Yuji Morine, Shuichi Iwahashi, Yu Saitou, Yusuke Arakawa, Satoru Imura, Hideki Arimochi and Mitsuo Shimada :
Branched chain amino acid suppressed insulin-initiated proliferation of human cancer cells through induction of autophagy.,
Anticancer Research, Vol.34, No.9, 4789-4796, 2014.
(PubMed: 25202059)
75. Gizachew Yismaw Wubetu, Tohru Utsunomiya, Daichi Ishikawa, Shinichiro Yamada, Tetsuya Ikemoto, Yuji Morine, Shuichi Iwahashi, Yu Saitou, Yusuke Arakawa, Satoru Imura, Mami Kanamoto, Chengzhan Zhu, Yoshimi Bando and Mitsuo Shimada :
High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.,
Annals of Surgical Oncology, Vol.21 Suppl 4, S721-8, 2014.
(Tokushima University Institutional Repository: 109697,   DOI: 10.1245/s10434-014-3861-9,   PubMed: 24965572)
76. Noriko Matsumoto, Yuji Morine, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Shiniciro Yamada, Daichi Ishikawa, Chie Takasu, Hidenori Miyake and Mitsuo Shimada :
Role of CD151 expression in gallbladder carcinoma.,
Surgery, Vol.156, No.5, 1212-1217, 2014.
(DOI: 10.1016/j.surg.2014.04.053,   PubMed: 24890568)
77. Chinbold Enkhbold, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, Daichi Ishikawa and Mitsuo Shimada :
Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma.,
Hepatology Research, Vol.44, No.14, E346-52, 2014.
(Tokushima University Institutional Repository: 109369,   DOI: 10.1111/hepr.12314,   PubMed: 24552289)
78. Shinichiro Yamada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusue Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, Chie Takasu, Daichi Ishikawa and Mitsuo Shimada :
Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.,
Annals of Surgical Oncology, Vol.21 Suppl 3, S436-42, 2014.
(DOI: 10.1245/s10434-014-3575-z,   PubMed: 24566861)
79. Akira Nii, Tohru Utsunomiya, Mitsuo Shimada, Toru Ikegami, Hiroki Ishibashi, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hajime Sasaki and Akihiro Kawashima :
A hydrolyzed whey peptide-based diet ameliorates hepatic ischemia-reperfusion injury in the rat nonalcoholic fatty liver.,
Surgery Today, Vol.44, No.12, 2354-2360, 2014.
(DOI: 10.1007/s00595-014-0853-0,   PubMed: 24492979)
80. Yusuke Arakawa, Mitsuo Shimada, 石川 大地, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Toru Utsunomiya :
3.肝疾患 ウイルス性肝炎,
日本臨床外科学会誌, Vol.69, No.11, 2014.
81. Shuichi Iwahashi, Satoru Imura, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Mami Kanamoto, Yu Saitou, Chie Takasu and Mitsuo Shimada :
肝移植,
日本臨床外科学会誌, Vol.69, No.4, 2014.
82. Shinichiro Yamada, Mitsuo Shimada, Tohru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi and Yu Saitou :
CXC receptor 4 and stromal cell-derived factor 1 in primary tumors and liver metastases of colorectal cancer.,
The Journal of Surgical Research, Vol.187, No.1, 107-112, 2013.
(DOI: 10.1016/j.jss.2013.10.030,   PubMed: 24238971)
83. Chie Takasu, Mitsuo Shimada, Hirohiko Sato, Tomohiko Miyatani, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mami Kanamoto, Nobuhiro Kurita, Shohei Eto and Tohru Utsunomiya :
Benefits of simultaneous laparoscopic resection of primary colorectal cancer and liver metastases.,
Asian Journal of Endoscopic Surgery, Vol.7, No.1, 31-37, 2013.
(DOI: 10.1111/ases.12066,   PubMed: 24127772)
84. Lkhagva-Ochir Tovuu, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Koji Sugimoto, Yu Saitou, Shinichiro Yamada, Michihito Asanoma and Mitsuo Shimada :
The role of Aurora B expression in non-tumor liver tissues of patients with hepatocellular carcinoma.,
International Journal of Clinical Oncology, Vol.19, No.4, 622-628, 2013.
(DOI: 10.1007/s10147-013-0593-y,   PubMed: 23893130)

Review, Commentary:

1. Yu Saitou, Yasuhiro Hamada, Sonoko Yasui-Yamada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
周術期の体組成評価:―サルコペニアの観点より―,
The Japanese Journal of Surgical Metabolism and Nutrition, Vol.53, No.4, 147-156, Aug. 2019.
(DOI: 10.11638/jssmn.53.4_147)
2. Yoichiro Kawashita, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shuichi Iwahashi, Shin-ichiro Yamada, Jun Higashijima, Satoru Imura, Hirohisa Ogawa, Toshiyuki Yagi and Mitsuo Shimada :
Loss of Fbxw7 expression is a predictor of recurrence in colorectal liver metastasis.,
Journal of Hepato-Biliary-Pancreatic Sciences, Vol.24, No.10, 576-583, Oct. 2017.
(Tokushima University Institutional Repository: 110995,   DOI: 10.1002/jhbp.500,   PubMed: 28846828)
3. Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Higashijima and Mitsuo Shimada :
Treatment strategy of conversion hepatectomy for colorectal liver metastasis,
Journal of Clinical Surgery, Vol.72, No.10, 1211-1216, Oct. 2017.
(CiNii: 1390283684865555456)
4. Shuichi Iwahashi, Hiroki Teraoku, Yu Saitou, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
【どこをどう切る?どうつなぐ?なぞって覚える!消化器外科術式理解イラストノート】 肝臓・胆道の手術 肝切除術,
Gastroenterological Surgery Nursing, Vol.22, No.8, 704-708, Oct. 2017.
5. Hideya Kashihara, Yuji Morine, Jun Higashijima, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
【胆膵進行癌に対する外科治療戦略】 閉塞性黄疸に対する最新の術前減黄戦略,
Surgery, Vol.79, No.8, 708-713, Aug. 2017.
6. Tetsuya Ikemoto, Mitsuo Shimada and Shinichiro Yamada :
Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation.,
Hepatology Research, Vol.47, No.1, 23-30, Jun. 2017.
(DOI: 10.1111/hepr.12705,   PubMed: 26990590)
7. Shin-ichiro Yamada, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Chie Takasu, Masato Yoshikawa, Hiroki Teraoku, Toshiaki Yoshimoto and Atsushi Takata :
Effective stepwise training and procedure standardization for young surgeons to perform laparoscopic left hepatectomy.,
Surgical Endoscopy, Vol.31, No.6, 2623-2629, Dec. 2016.
(DOI: 10.1007/s00464-016-5273-3,   PubMed: 27928671)
8. Shinichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Masato Yoshikawa, Hiroki Teraoku and Mitsuo Shimada :
Liver regeneration after splenectomy in patients with liver cirrhosis.,
Hepatology Research, Vol.46, No.5, 443-449, Oct. 2016.
(DOI: 10.1111/hepr.12573,   PubMed: 26428414)
9. Shuichi Iwahashi, Mitsuo Shimada, Tohru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Chie Takasu, Yu Saitou and Shinichiro Yamada :
Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation.,
Cancer Letters, Vol.375, No.1, 47-50, Mar. 2016.
(DOI: 10.1016/j.canlet.2016.02.041,   PubMed: 26940140)
10. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Satoru Imura, Yu Saitou and Shin-ichiro Yamada :
【最新 肝胆膵高難度外科手術アトラス】 高難度外科手術手技 肝臓 肝下部下大静脈再建を伴う肝切除,
Operation, Vol.70, No.4, 431-438, Mar. 2016.
11. Yu Saitou, Yasuhiro Hamada, Sonoko Yasui, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
【外科領域におけるサルコペニア】 周術期サルコペニア発生の予防法,
The Japanese Journal of Surgical Metabolism and Nutrition, Vol.50, No.1, 21-28, Feb. 2016.
12. Gizachew Yismaw Wubetu, Yuji Morine, Hiroki Teraoku, Masato Yoshikawa, Daichi Ishikawa, Shinichiro Yamada, Tetsuya Ikemoto, Yu Saitou, Satoru Imura and Mitsuo Shimada :
High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.,
Anticancer Research, Vol.36, No.2, 757-762, Feb. 2016.
(PubMed: 26851035,   Elsevier: Scopus)
13. Mandakhnaran Davaadorj, Satoru Imura, Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shinichiro Yamada, Chie Takasu, Teraoku Hiroki, Masato Yoshikawa and Mitsuo Shimada :
Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.,
Anticancer Research, Vol.36, No.2, 659-664, Feb. 2016.
(PubMed: 26851021,   Elsevier: Scopus)
14. Gizachew Y. Wubetu, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Daichi Ishikawa, Shuichi Iwahashi, Shinichiro Yamada, Yu Saitou, Yusuke Arakawa and Satoru Imura :
Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.,
Journal of Gastroenterology and Hepatology, Vol.31, No.1, 256-264, Jan. 2016.
(DOI: 10.1111/jgh.13069,   PubMed: 26241688)
15. Hiroki Teraoku, Yusuke Arakawa, Masato Yoshikawa, Shinichiro Yamada, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
Complication of portal vein thrombosis after right hemihepatectomy in a patient lacking the portal vein bifurcation.,
The Journal of Medical Investigation : JMI, Vol.63, No.3-4, 315-318, 2016.
(Tokushima University Institutional Repository: 111201,   DOI: 10.2152/jmi.63.315,   PubMed: 27644579)
16. Yu Saitou, Sonoko Yasui, Yasuhiro Hamada, Chie Takasu, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
肝胆膵手術例の術前栄養管理,
Surgery, Vol.76, No.11, 1201-1209, Nov. 2014.
17. C Enkhbold, Mitsuo Shimada, Toru Utsunomiya, Hiroki Ishibashi, S Yamada, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine and Satoru Imura :
One-stop shop for 3-dimensional anatomy of hepatic vasculature and bile duct with special reference to biliary image reconstruction.,
Hepato-Gastroenterology, Vol.60, No.128, 1861-1864, Nov. 2013.
(DOI: 10.5754/hge13536,   PubMed: 24088317)
18. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Chie Takasu :
Effects of splenectomy on hepatic gene expression profiles after massive hepatectomy in rats.,
Journal of Gastroenterology and Hepatology, Vol.28, No.10, 1669-1677, Oct. 2013.
(DOI: 10.1111/jgh.12316,   PubMed: 23808869,   Elsevier: Scopus)
19. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, 山田 眞一郎, Chie Takasu and Hidenori Miyake :
【各種デバイスを応用した私の手術―使用法と工夫】各種デバイスを応用した肝・胆手術,
Surgery, Vol.75, No.9, 954-959, Sep. 2013.
20. Shuichi Iwahashi, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Toru Utsunomiya, Yuji Morine, Yusuke Arakawa and Mami Kanamoto :
【いつ何が大事かがわかる 消化器外科術後の看護ポイント】 腹腔鏡下胆嚢摘出術後の看護・観察ポイント 0∼12時間,12∼24時間,24∼72時間,
Gastroenterological Surgery Nursing, Vol.18, No.8, 696-704, Aug. 2013.
21. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mami Kanamoto and Shuichi Iwahashi :
【大腸癌肝転移up to date】大腸癌肝転移化学療法後の肝障害,
Surgery, Vol.75, No.8, 828-833, Aug. 2013.
22. T Toshima, Mitsuo Shimada, Toru Ikegami, Toru Utsunomiya, Tetsuya Ikemoto, Yuji Morine, Tomoharu Yoshizumi, Yuji Soejima, K Shirabe and Y Maehara :
Fairly rare spontaneous disappearance of a hepatic artery aneurysm following living donor liver transplantation.,
Liver Transplantation, Vol.19, No.8, 929-930, Aug. 2013.
(DOI: 10.1002/lt.23676,   PubMed: 23696536,   Elsevier: Scopus)
23. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto and Hiroki Mori :
Significance of sonic hedgehog signaling after massive hepatectomy in a rat.,
Surgery Today, Vol.43, No.3, 300-307, Jun. 2013.
(DOI: 10.1007/s00595-012-0248-z,   PubMed: 22790641)
24. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, 杉本 光司 and Yoshimi Bando :
Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors.,
Hepatology Research, Vol.43, No.6, 685-689, Jun. 2013.
(DOI: 10.1111/j.1872-034X.2012.01114.x,   PubMed: 23730707,   Elsevier: Scopus)
25. Shuichi Iwahashi, Toru Utsunomiya, Mitsuo Shimada, Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Yoshimi Bando :
High expressions of cancer stem cell markers in cholangiolocellular carcinoma.,
Surgery Today, Vol.43, No.6, 654-660, Jun. 2013.
(Tokushima University Institutional Repository: 115811,   DOI: 10.1007/s00595-012-0437-9,   PubMed: 23192764,   Elsevier: Scopus)
26. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine and Tetsuya Ikemoto :
【最新 肝胆膵脾手術アトラス】肝臓 右下肝静脈存在下での肝切除術,
Operation, Vol.67, No.6, 715-720, May 2013.
27. Tetsuya Ikemoto, M Takita, MF Levy, Mitsuo Shimada and B Naziruddin :
CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.,
Cellular Immunology, Vol.283, No.1-2, 81-90, May 2013.
(DOI: 10.1016/j.cellimm.2013.06.004,   PubMed: 23933136,   Elsevier: Scopus)
28. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa and Mami Kanamoto :
【エキスパートが教える内視鏡外科手術・ポイントとなる解剖の理解】 肝・胆・膵・脾の鏡視下手術 肝癌に対する鏡視下手術 腹腔鏡下肝部分切除術,
Gastroenterological Surgery, Vol.36, No.5, 779-785, Apr. 2013.
29. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Tetsuya Ikemoto, 山田 眞一郎, Yuji Morine, Satoru Imura, Hiroki Mori, 杉本 光司, Shuichi Iwahashi and 浅野間 理仁 :
The protective effect of adipose-derived stem cells against liver injury by trophic molecules.,
The Journal of Surgical Research, Vol.180, No.1, 162-168, Mar. 2013.
(Tokushima University Institutional Repository: 105888,   DOI: 10.1016/j.jss.2012.10.009,   PubMed: 23117122,   Elsevier: Scopus)
30. Hiroki Mori, Mitsuo Shimada, Toru Utsunomiya, Hiroki Ishibashi, Horohiko Sato, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, 淺野間 理仁, 山田 眞一郎, 石川 大地 and Hidenori Miyake :
【膵・胆管合流異常診療ガイドラインを巡る残された問題点】 非拡張型膵・胆管合流異常の胆管癌発生頻度を巡る問題点,
Journal of Biliary Tract & Pancreas, Vol.34, No.3, 241-244, Mar. 2013.
31. Tetsuya Ikemoto, Mitsuo Shimada, Shuichi Iwahashi, Yu Saitou, Mami Kanamoto, Hiroki Mori, Yuji Morine, Satoru Imura and Toru Utsunomiya :
Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer.,
International Journal of Clinical Oncology, Vol.19, No.1, 81-86, Mar. 2013.
(DOI: 10.1007/s10147-013-0529-6,   PubMed: 23443635,   Elsevier: Scopus)
32. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, 山田 眞一郎 and 浅野間 理仁 :
Regulatory T cells in the blood: a new marker of surgical stress.,
Surgery Today, Vol.43, No.6, 608-612, Jan. 2013.
(DOI: 10.1007/s00595-013-0517-5,   CiNii: 1573105975985904384)
33. Tetsuya Ikemoto, Mitsuo Shimada, Masato Komatsu, Shinichiro Yamada, Yu Saito, Hiroki Mori, Yuji Morine, Satoru Imura, Yoshimi Bando and Toru Utsunomiya :
Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood.,
Pancreas, Vol.42, No.1, 130-134, Jan. 2013.
(DOI: 10.1097/MPA.0b013e3182575e4a,   PubMed: 22722263,   Elsevier: Scopus)
34. 石川 大地, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, 山田 眞一郎 and 浅野間 理仁 :
Atypically large well-differentiated hepatocellular carcinoma with extensive fatty metamorphosis: report of a case.,
The Journal of Medical Investigation : JMI, Vol.60, No.3-4, 267-271, 2013.
(Tokushima University Institutional Repository: 106367,   DOI: 10.2152/jmi.60.267,   PubMed: 24190046,   Elsevier: Scopus)
35. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, Shuichi Iwahashi, 山田 眞一郎, 浅野間 理仁 and Hiroki Ishibashi :
Hepatic epithelioid angiomyolipoma with arterioportal venous shunting mimicking hepatocellular carcinoma : report of a case.,
The Journal of Medical Investigation : JMI, Vol.60, No.3-4, 262-266, 2013.
(Tokushima University Institutional Repository: 106366,   DOI: 10.2152/jmi.60.262,   PubMed: 24190045)
36. 杉本 光司, Toru Utsunomiya, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Chie Takasu and Mitsuo Shimada :
Hand-assisted laparoscopic splenectomy for a huge splenic vascular lesion with aneurysms in a patient with impending Kasabach-Merritt syndrome-like phenomenon.,
The Journal of Medical Investigation : JMI, Vol.60, No.3-4, 276-279, 2013.
(Tokushima University Institutional Repository: 106369,   DOI: 10.2152/jmi.60.276,   PubMed: 24190048,   Elsevier: Scopus)
37. Shinichiro Yamada, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Mami Kanamoto, Jun Hanaoka, Shuichi Iwahashi, Yu Saitou and Hiroki Ishibashi :
Hilar cholangiocarcinoma accompanied by pancreaticobiliary maljunction without bile duct dilatation 20 years after cholecystectomy: report of a case,
The Journal of Medical Investigation : JMI, Vol.60, No.1-2, 169-173, 2013.
(Tokushima University Institutional Repository: 106060,   DOI: 10.2152/jmi.60.169,   PubMed: 23614928)
38. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Jun Hanaoka :
Effects of a whey peptide-based enteral formula diet on liver dysfunction following living donor liver transplantation.,
Surgery Today, Dec. 2012.
(DOI: 10.1007/s00595-012-0466-4,   PubMed: 23266751)
39. Hiroki Mori, Mitsuo Shimada, Toru Ikegami, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, 齋藤 裕, 淺野間 理仁, 山田 眞一郎 and Hidenori Miyake :
The Impact of Pegylated-Interferon alpha-2b on Partial and Massive Hepatectomy Model in Rats.,
Hepato-Gastroenterology, Vol.59, No.119, 2300-2304, Oct. 2012.
(DOI: 10.5754/hge10401,   PubMed: 23435145)
40. 齋藤 裕, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 山田 眞一郎 and 淺野間 理仁 :
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.,
Hepatology Research, Vol.42, No.9, 887-894, Sep. 2012.
(DOI: 10.1111/j.1872-034X.2012.01004.x,   PubMed: 22524419)
41. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Mami Kanamoto, Jun Hanaoka, Shuichi Iwahashi and 齋藤 裕 :
Surgical results of pancreatoduodenectomy in elderly patients.,
Surgery Today, Vol.42, No.9, 857-862, Sep. 2012.
(DOI: 10.1007/s00595-012-0169-x,   PubMed: 22447454)
42. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, 齋藤 裕, Shuichi Iwahashi, Jun Hanaoka, Hiroki Mori, Tetsuya Ikemoto and Yuji Morine :
Impact of a new refrigerator on the preservation of hepatic grafts.,
Hepatology Research, Vol.42, No.8, 798-805, Aug. 2012.
(DOI: 10.1111/j.1872-034X.2012.00987.x,   PubMed: 22469252)
43. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, 齋藤 裕 and Hidenori Miyake :
A Modified liver-hanging maneuver focusing on the ligamentum venosum in left hepatic lobectomy,
Surgery Today, Vol.42, No.8, 720-723, Aug. 2012.
(DOI: 10.1007/s00595-011-0051-2,   PubMed: 22094437)
44. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Hiroki Mori :
Huge focal nodular hyperplasia difficult to distinguish from well-differentiated hepatocellular carcinoma,
Hepatology Research, Vol.42, No.7, 727-731, Jul. 2012.
(DOI: 10.1111/j.1872-034X.2012.00974.x,   PubMed: 22686861)
45. LO Tovuu, Satoru Imura, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 杉本 光司, Shuichi Iwahashi, Yu Saitou, 山田 眞一郎, 淺野間 理仁, Hidenori Miyake and Mitsuo Shimada :
Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma.,
International Journal of Clinical Oncology, Vol.18, No.4, 651-656, Jun. 2012.
(Tokushima University Institutional Repository: 106069,   DOI: 10.1007/s10147-012-0432-6,   PubMed: 22706704)
46. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori and Jun Hanaoka :
Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in gallbladder carcinoma,
Surgery Today, Vol.42, No.6, 565-569, Jun. 2012.
(DOI: 10.1007/s00595-012-0118-8,   PubMed: 22270332)
47. Satoru Imura, Mitsuo Shimada, 齋藤 裕, Shuichi Iwahashi, Jun Hanaoka, Hiroki Mori, Tetsuya Ikemoto, Yuji Morine and Toru Utsunomiya :
Successful case with hemophagocytic syndrome after living donor liver transplantation.,
Hepato-Gastroenterology, Vol.59, No.115, 863-865, May 2012.
(DOI: 10.5754/hge10081,   PubMed: 22469732)
48. 山田 眞一郎, Mitsuo Shimada, Hidenori Miyake, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi and 齋藤 裕 :
Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma.,
Hepatology Research, Vol.42, No.5, 454-458, May 2012.
(DOI: 10.1111/j.1872-034X.2011.00952.x,   PubMed: 22295877)
49. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, 齋藤 裕 and 淺野間 理仁 :
Hepatic screlosed hemangioma which was misdiagnosed as metastasis of gastric cancer: report of a case,
The Journal of Medical Investigation : JMI, Vol.59, No.3-4, 270-274, 2012.
(Tokushima University Institutional Repository: 106032,   DOI: 10.2152/jmi.59.270,   PubMed: 23037199)
50. Yuji Morine, Masahiko Fujii, Satoru Imura, Tetsuya Ikemoto and Mitsuo Shimada :
特集 肝移植の最新の進歩と問題点 選択,適応基準とIC取得,実践時期の設定 肝細胞癌に対する肝移植,
KAN TAN SUI, Vol.50, No.1, 75-84, Jan. 2005.

Proceeding of International Conference:

1. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki and Mitsuo Shimada :
Preoperative weight loss program for HCC patients with high body mass index in hepatectomy.,
APASL 2024 Kyoto(アジア太平洋肝臓学会), Kyoto, Mar. 2024.
2. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Yuhei Waki and Mitsuo Shimada :
New onlocogical resectability of CRLM and multidisciplinary treatment strategy,
APASL 2024 Kyoto(アジア太平洋肝臓学会), Kyoto, Mar. 2024.
3. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
Preoperative weight loss program for hepatocellular carcinoma patients with high body mass index in hepatectomy.,
ASCO-GI 2024, San Francisco, Jan. 2024.
4. Hiroki Teraoku, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou and Shin-ichiro Yamada :
Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma,
IHPBA2020, Melbourne, Nov. 2020.
5. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou and Shin-ichiro Yamada :
Treatment Strategy for Synchronous Liver Metastases from Colorectal Cancer,
IHPBA2020, Melbourne, Nov. 2020.
6. Kazunori Tokuda, Mitsuo Shimada, Tetsuya Ikemoto, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Yusuke Arakawa, Satoru Imura and Yuji Morine :
The investigation of optimal transplantation site of insulin producing cell differentiated from human adipose derived stem cell.,
ISCT2020, Paris, May 2020.
(DOI: 10.1016/j.jcyt.2020.03.194)
7. Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Shin-ichiro Yamada, Yusuke Arakawa, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Effective 3D culture of hepatocyte like cells from human adipose derived mesenchymal stem cells.,
ISCT2020, Paris, May 2020.
(DOI: 10.1016/j.jcyt.2020.03.178)
8. Tetsuya Ikemoto, Mitsuo Shimada, Kazunori Tokuda, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Yusuke Arakawa, Satoru Imura and Yuji Morine :
The generation of effective insulin-producing cells from ADSC derived from type 1 diabetes mellitus patients.,
ISCT2020, Paris, May 2020.
(DOI: 10.1016/j.jcyt.2020.03.147)
9. Mitsuo Shimada, Tetsuya Ikemoto, Kazunori Tokuda, Yu Saitou, Katsuki Miyazaki, Yusuke Arakawa, Satoru Imura and Yuji Morine :
Long-term results of transplanted insulin producing cells differented from human adipose stem cells in mice.,
ISCT2020, Paris, May 2020.
(DOI: 10.1016/j.jcyt.2020.03.186)
10. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa and Katsuki Miyazaki :
Significance of frailty in prognosis after hepatectomy in older patients with hepatocellular carcinoma.,
ASCO-GI, San Francisco, Jan. 2020.
(DOI: 10.1245/s10434-020-08742-w,   PubMed: 32562115)
11. Yusuke Arakawa, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Katsuki Miyazaki :
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.,
ASCO-GI, San Francisco, Jan. 2020.
(DOI: 10.1200/JCO.2020.38.4_suppl.756)
12. Masato Yoshikawa, Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou and Katsuki Miyazaki :
Prognostic prediction of mass-forming intrahepatic cholangiocarcinoma from ADC value of DWI-MRI,
IASGO2019, Bangkok, Oct. 2019.
13. Katsuki Miyazaki, Tetsuya Ikemoto, Mitsuo Shimada, Feng Rui, Yu Saitou, Shuichi Iwahashi, Yuji Morine and Satoru Imura :
THE IMPACT OF RED LED IRRADIATION ON DIFFERENTIATION FOR INSULIN-PRODUCING CELLS FROM MESENCHYMAL STEM CELL,
ESOT2019, Copenhagen, Sep. 2019.
14. Yu Saitou, Shogo Oota, Tetsuya Ikemoto, Shuichi Iwahashi, Yuji Morine, Satoru Imura, Shin-ichiro Yamada and Mitsuo Shimada :
THE NEW ROLE OF ZINC ION IN INSULIN-PRODUCING CELLS DIFFERENTIATION FROM ADIPOSE DERIVED MESENCHYMAL STEM CELLS.,
ESOT2019, Copenhagen, Sep. 2019.
15. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Feng Rui, Shin-ichiro Yamada, Shuichi Iwahashi, Yuji Morine and Satoru Imura :
THE POTNETIALLY CLINICAL APPLICATION OF XENO-ANTIGEN FREE DIFFERENTIATION PROTOCOL FOR INSULINPRODUCING CELLS USING HUMAN RECOMBINANT PEPTIDE PETALOID Μ-PIECE FROM ADIPOSE-TISSUE DERIVED MESENCHYMAL STEM CELL,
ESOT2019, Copenhagen, Sep. 2019.
16. Mitsuo Shimada, Tetsuya Ikemoto, Yuuma Wada, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada and Shogo Oota :
Characteristic difference of adiposederived mesenchymal stem cells from subcutaneous and visceral fat tissue for generating insulin-producing cell,
ESOT2019, Copenhagen, Sep. 2019.
17. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou and Shin-ichiro Yamada :
Standardization of surgical technique in laparoscopic distal pancreatectomy,
SAGES 2019, Baltimore, Apr. 2019.
18. Shin-ichiro Yamada, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Toshiaki Yoshimoto, Masaaki Nishi and Chie Takasu :
Prognostic Prediction of Mass-Forming Intrahepatic Cholangiocarcinoma from Diffusion Weighted Image of Magnetic Resonance Image,
SSO's 72nd Annual Cancer Symposium, San Diego, Mar. 2019.
19. Shogo Oota, Shuichi Iwahashi, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
The feasibility of hepatectomy for the super-elderly patients with HCC.,
ASCO-GI, San Francisco, Jan. 2019.
(DOI: 10.1200/JCO.2019.37.4_suppl.274)
20. Shuichi Iwahashi, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and 馮 睿 :
The effect of hepatic stellate cells on hepatocellular carcinoma progression.,
ASCO-GI, San Francisco, Jan. 2019.
(DOI: 10.1200/JCO.2019.37.4_suppl.265)
21. Satoru Imura, Shin-ichiro Yamada, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Validity of hepatic cone-unit resection for hepatocellular carcinoma.,
ASCO-GI, San Francisco, Jan. 2019.
(DOI: 10.1200/JCO.2019.37.4_suppl.228)
22. Mitsuo Shimada, Hiroki Teraoku, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Chie Takasu and Shin-ichiro Yamada :
Role of central hypovascularity in the hepatic arterial phase of dynamic CT on mass-forming intrahepatic cholangiocarcinoma.,
ASCO-GI, San Francisco, Jan. 2019.
(DOI: 10.1200/JCO.2019.37.4_suppl.205)
23. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Shin-ichiro Yamada :
The approach for establishing safe, reliable and rapid pancreatoduodenectomy,
第9回日本・モンゴル国際消化器癌シンポジウム, Aug. 2018.
24. Satoru Imura, Hiroki Teraoku, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Outcome of left lobe living-donor liver transplantation in Tokushima,
27th International Congress of The Transplantation Society(TTS), Jun. 2018.
25. Yu Saitou, Rui Feng, Chie Takasu, Tetsuya Ikemoto, Shuichi Iwahashi, Hiroki Teraoku, Yuji Morine, Satoru Imura and Mitsuo Shimada :
Establishment of effective differentiation protocols for insulin-producing cells using a new 3D culture system from adipose-tissue derived mesenchymal stem cell,
27th International Congress of The Transplantation Society(TTS), Jun. 2018.
26. Mitsuo Shimada, Rui Feng, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou and Chie Takasu :
Establishment of insulin producing cells differentiated from human adipose-derived mesenchymal stem cells using a 3D-culture system with xenoantigen free reagents,
27th International Congress of The Transplantation Society(TTS), Jun. 2018.
27. Yuuma Wada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto and Mitsuo Shimada :
Significance of hypoxia inducible factor-1αexpression in colorectal liver metastasis.,
APASL STC2018, Yokohama, May 2018.
28. Toshiaki Yoshimoto, Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shuichi Iwahashi, Hiroki Teraoku and Mitsuo Shimada :
The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Sorafenib therapy combined with surgical resection or TACE,
APASL STC2018, Yokohama, May 2018.
29. Shuichi Iwahashi, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yu Saitou and Hiroki Teraoku :
Reduced-port laparoscopic cholecystectomy for young surgeons,
SAGES, Seattle, Apr. 2018.
30. Satoru Imura, Hiroki Teraoku, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Laparoscopic hemi-hepatectomy for liver tumor,
SAGES, Seattle, Apr. 2018.
31. Mitsuo Shimada, Shuichi Iwahashi, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Jun Higashijima :
Usefulness of one-stop shop simulation for liver surgery using EOB-MRI.,
SAGES, Seattle, Apr. 2018.
32. Yuuma Wada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Hiroki Teraoku, Shogo Oota, Jun Higashijima and Mitsuo Shimada :
Significance of hypoxia inducible factor-1 expression in liver metastasis of colorectal cancer.,
ASCO-GI, San Francisco, Jan. 2018.
33. Yuji Morine, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
Reduction of T-Box 15gene expression in tumor tissue as a prognostic biomarker for patients with heparocellular carcinoma.,
ASCO-GI, San Francisco, Jan. 2018.
34. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shuichi Iwahashi, Masato Yoshikawa, Toshiaki Yoshimoto and Mitsuo Shimada :
Preoperative Prognostic Nutritional Index Predicts Both Short-and Long-Term Outcomes after Liver Resection For Hepatocellular Carcinoma,
AMERICAN COLLEGE OF SURGEONS 2017(ACS), San Diego, Oct. 2017.
35. Tetsuya Ikemoto, Mitsuo Shimada, Shuichi Iwahashi, Rui Feng, Yu Saitou, Satoru Imura and Yuji Morine :
The establishmenmt of effective differentiation protocols for insulin-producing cells using 3D culture system from rat adipose-tissue derived mesenchymal stem cell,
18th Congress of the European Society for Organ Transplantation(ESOT), Barcelona, Sep. 2017.
36. Masaaki Nishi, Mitsuo Shimada, Tetsuya Ikemoto, Jun Higashijima, Kouzou Yoshikawa, Hideya Kashihara, Chie Takasu and Daichi Ishikawa :
Prognostic impact of neutrophil-to-lymphocyte ratio in patients with rectal cancer after preoperative chemoradiotherapy,
47th World Congress of Surgery(WCS), バーゼル, Aug. 2017.
37. Rui Feng, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Kouzou Yoshikawa, Toshiaki Yoshimoto and Jun Higashijima :
The impact of red LED irradiation on hepatocytes preservation,
18th Congress of the European Society for Organ Transplantation(ESOT)2017, Barcelona, Aug. 2017.
38. Mitsuo Shimada, Rui Feng, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Shuichi Iwahashi, Yu Saitou, Toshiaki Yoshimoto and Jun Higashijima :
A new 2-step protocol for human adipose derived mesenchymal stem cell differentiation to insulin-producing cells using xeno-antigen free reagents,
18th Congress of the European Society for Organ Transplantation(ESOT), Barcelona, Aug. 2017.
39. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Shuichi Iwahashi, Masaaki Nishi, Jun Higashijima, Satoru Imura and Yuji Morine :
Clinical impact of Tr1 and FOXP3+regulatory Tcell as precise immunological biomarkers for reflecting cancer status,
47th World Congress of Surgery(WCS), バーゼル, Aug. 2017.
40. Shuichi Iwahashi, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yu Saitou and Masato Yoshikawa :
Reduced-port laparoscopic cholecystectomy with 3mm minute-diameter forceps.,
SAGES, Houston, Mar. 2017.
41. Satoru Imura, Atsushi Takata, Toshiaki Yoshimoto, Masato Yoshikawa, Hiroki Teraoku, Daichi Ishikawa, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Comparative analysis of the outcome between open and laparoscopic partial liver resection for hepatocellular carcinoma.,
SAGES, Houston, Mar. 2017.
42. Mitsuo Shimada, Shuichi Iwahashi, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Masato Yoshikawa and Jun Higashijima :
New technology of `One-stop shop' liver surgery simulation equipped with assessment of total and regional liver functional reserve.,
SAGES, Houston, Mar. 2017.
43. Yu Saitou, Yuji Morine, Chie Takasu, Shuichi Iwahashi, Jun Higashijima, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
Role of HSF1 expression for tumor microenvironment in intrahepatic cholangiocarcinoma.,
ASCO-GI, San Francisco, Jan. 2017.
(DOI: 10.1200/JCO.2017.35.4_suppl.249)
44. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Daichi Ishikawa, Hiroki Teraoku, Masato Yoshikawa and Jun Higashijima :
Treatment strategy for colorectal liver metastases:Clinical impact of FOLFOXIRI regimen for unresectable cases.,
ASCO-GI, San Francisco, Jan. 2017.
(DOI: 10.1200/JCO.2017.35.4_suppl.780)
45. Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Masato Yoshikawa, Hiroki Teraoku and Jun Higashijima :
Characteristics of intrahepatic cholangiocarcinoma according to tumor location.,
ASCO-GI, San Francisco, Jan. 2017.
(DOI: 10.1200/JCO.2017.35.4_suppl.406)
46. Masato Yoshikawa, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Atsushi Takata and Toshiaki Yoshimoto :
Current status and effect of laparoscopic training for young surgeon,
40th World Congress of the International College of Surgeons (ICS 2016), Kyoto, Oct. 2016.
47. Daichi Ishikawa, Tetsuya Ikemoto, Toshiaki Yoshimoto, Atsushi Takata, Masato Yoshikawa, Chie Takasu, Yu Saitou, Shuichi Iwahashi, Yuji Morine, Satoru Imura and Mitsuo Shimada :
Signigficance of CD4+CD49b+regulatory T cells and Foxp3+regulatory T cells in the peripheral blood of cancer patients,
40th World Congress of the International College of Surgeons (ICS 2016), Kyoto, Oct. 2016.
48. Shuichi Iwahashi, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Masato Yoshikawa, Atsushi Takata and Toshiaki Yoshimoto :
Recurrent feature after radiofrequency ablation therapy for hepatocellular carcinoma,
4th International Conference of FACO, 廈門, Sep. 2016.
49. Masato Yoshikawa, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Daichi Ishikawa, Atsushi Takata and Toshiaki Yoshimoto :
Elevated preoperative serum CEA levels in patients with HCC is associated with prognosis and EMT,
26th World Congress Of the IASGO 2016, Seoul, Sep. 2016.
50. Masato Yoshikawa, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Atsushi Takata and Toshiaki Yoshimoto :
Elevated preoperative serum CEA levels in patients with HCC is associated with prognosis and EMT,
第8回日本・モンゴル消化器癌国際シンポジウム, ウランバートル, Aug. 2016.
51. Satoru Imura, Masato Yoshikawa, Daichi Ishikawa, Yu Saitou, Shuichi Iwahashi, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Our strategy for antibody mediated rejection in living donor liver transplantation,
第8回日本・モンゴル消化器癌国際シンポジウム, ウランバートル, Aug. 2016.
52. Atsushi Takata, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shuichi Iwahashi, Yu Saitou, Daichi Ishikawa, Kouzou Yoshikawa and Toshiaki Yoshimoto :
The correlation between serum CA19-9 level and the epigenetic alteration in intrahepatic cholangiocarcinoma.,
IASGO Advanced Post-Graduate Course in Sendai 2016, Sendai, Apr. 2016.
53. Yu Saitou, Atsushi Takata, Hiroki Teraoku, Masato Yoshikawa, Shin-ichiro Yamada, Tetsuya Ikemoto, Yuji Morine, Satoru Imura and Mitsuo Shimada :
The effect od HDACi in ADSC differentiation in to insulin producing cells.,
Transplantation Science Symposium (TSS) Asian Regional Meeting 2016, Tokyo, Apr. 2016.
54. Satoru Imura, Takuya Tokunaga, Masayuki Sumitomo, Shin-ichiro Yamada, Chie Takasu, Yu Saitou, Jun Higashijima, Kouzou Yoshikawa, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Usefulness of telementoring system to develop laparoscopic surgery in rural hospital,
Society American Gastrointestinal Endoscopic Surgeons (SAGES 2016), Boston, Mar. 2016.
55. Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yamada Shinichiro, Teraoku Hiroki, Yoshikawa Masato and Chie Takasu :
Effective stepwise training and procedure-standardization for young surgeons to perform laparoscopic left hepatectomy.,
Society American Gastrointestinal Endoscopic Surgeons (SAGES 2016), Boston, Mar. 2016.
56. Yoshikawa Masato, Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Yamada Shinichiro, Yoshimoto Toshiaki and Takata Atsushi :
Elevated preoperative serum CEA levels in patients with HCC is associated with prognosis and EMT.,
The Asian Pacific Association for the Study of the Liver, Tokyo, Feb. 2016.
57. Shinichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Teraoku Hiroki, Yoshikawa Masato, Yoshimoto Toshiaki and Takata Atsushi :
High NEK2 expression in hepatocellular carcinoma patients after hepatectomy,
The Asian Pacific Association for the Study of the Liver, Tokyo, Feb. 2016.
58. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Hiroki Teraoku :
Treatment strategy for intrahepatic cholangiocarcinoma: From optimal surgical management to adjuvant therapy.,
2016 Gastrointestinal Cancers Symposium, San Francisco, Jan. 2016.
59. Tetsuya Ikemoto :
The clinical impact of CD4+CD49b+regulatory T cells addition to Foxp3+regulatory T cells in cancer patients'immunity,
ACS Chicago 2015, Oct. 2015.
60. Tetsuya Ikemoto :
Japanese Kampo medicine TJ-114 prevebts autoimmune diabetes onsets in nod mice through CD4+CD49B+regulatory T cells,
17th Congress of the European Society for Organ Transplantation (ESOT)2015, Sep. 2015.
61. Teraoku Hiroki, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Higashijima, Yu Saitou and Chie Takasu :
The expression of KI-67 is a useful prognostic factor in patients with colorectal liver metastasis.,
46th World Congress of Surgery (WCS)2015, Aug. 2015.
62. Teraoku Hiroki, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Chie Takasu, Shin-ichiro Yamada, Daichi Ishikawa and Yoshikawa Masato :
The expression of Ki-67 is a useful prognostic factor in patients with colorectal liver metastasis,
IASGO 2015 post graduate course, Tokyo, Jun. 2015.
63. 良元 俊昭, GY Wubetu, Shin-ichiro Yamada, 石川 大地, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou and Mitsuo Shimada :
Impact of STAT4 expression on cellular immunity and prognosis in hepatocellular carcinoma.,
ASCO-GI 2015 Gastrointestinal Cancers Symposium, Jan. 2015.
64. Shuichi Iwahashi, Yismaw Gizachew, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, 吉川 雅登, 寺奥 大貴 and Mitsuo Shimada :
The antitumor effect of epigallocatechin-3-gallate on gastroenterological cancer.,
ASCO-GI 2015 Gastrointestinal Cancers Symposium, Jan. 2015.
65. Satoru Imura, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, Hiroshi Shibata and Hidenori Miyake :
Long-term survivors after sorafenib therapy in unresectable hepatocellular carcinoma.,
ASCO-GI 2015 Gastrointestinal Cancers Symposium, Jan. 2015.
66. Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shuichi Iwahashi, Yu Saitou, Shin-ichiro Yamada, 寺奥 大貴, 吉川 雅登, Jun Higashijima and Chie Takasu :
Impact of FOLFOXIRI regimen on early ``Conversion'' and long-term outcome in patients with initially unresectable colorectal liver metastases,
ASCO-GI 2015 Gastrointestinal Cancers Symposium, Jan. 2015.
67. Hisami Okumura, K Sugihara, M Yamamoto, Yutaka Taketani, Tetsuya Ikemoto, Yusuke Arakawa, Satoru Imura, Yuji Morine, Satoru Imura, Mitsuo Shimada and Eiji Takeda :
Recovery of non-protein respiratory quotient and health related quality of life after living-donor liver transplantation,
36th European Congress for Nutrition and Metabolism, Sep. 2014.
68. Hisami Okumura, Kohei Sugihara, Momo Yamamoto, Yutaka Taketani, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Mitsuo Shimada and Eiji Takeda :
Recovery of non-protein respiratory quotient and health related quality of life after living-donor liver transplantation.,
36th European Congress for Nutrition and Metabolism, Geneva, Switzerland 2014, September 6-9, Sep. 2014.
69. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto and Shuichi Iwahashi :
Useless of 3D-virtual hepatectomy and intraoperative navigation system in liver resection,
第28回国際コンピュータ支援放射線医学・外科学会議(CARS), Fukuoka, Jun. 2014.
70. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto and Yu Saitou :
Effects of valporic acid as a histone deacetylase inhibitor in combination with S-1 on advanced pancreatobiliary tract cancers:Clinical study phases and .,
Gastrointestinal Cancers Symposium(ASCO-GI), San Francisco, Jan. 2014.
71. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Yusuke Arakawa, Hiroki Mori, Mami Kanamoto, Shuichi Iwahashi and Yu Saitou :
Clinical impact of reflection to expression of EMT marker in intraductal papillary mucinous neoplasm.,
Gastrointestial Cancers Symposium(ASCO-GI), Jan. 2014.
72. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, D Ishikawa, Chie Mikami, Z Chengzhan, A Tajima and I Imoto :
Identification of aberrant DNA methylation profiles in non-tumor liver tissues of patients with non-B, non-C hepatocellular carcinoma.,
Gastrointestinal Cancers Symposium(ASCO-GI), San Francisco, Jan. 2014.
73. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto and Yu Saitou :
Effects of valproic acid as a histone deacetylase inhibitor in combination with S-1 on advanced pancreatobiliary tract cancers: Clinical study phases I and II.,
Gastrointestinal Cancers Symposium(ASCO-GI), San Francisco, Jan. 2014.
74. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Yusuke Arakawa, Hiroki Mori, Mami Kanamoto, Shuichi Iwahashi and Yu Saitou :
Clinical impact of reflection to expression of EMT marker in intraductal papillary mucinous neoplasm.,
Gastrointestinal Cancers Symposium(ASCO-GI), San Francisco, Jan. 2014.
75. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, Daichi Ishikawa, Chie Takasu, Chengzhan Zhu, Tajima A and Imoto I :
Identification of aberrant DNA methylation profiles in non-tumor liver tissues of patients with non-B, non-C hepatocellular carcinoma.,
Gastrointestinal Cancers Symposium(ASCO-GI), San Francisco, Jan. 2014.
76. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou and Chie Takasu :
Potential Predictive Factors for Microscopic Portal Invasion in Hepatocellular Carcinoma wwithout Macroscopic Vascular Invasion.,
American College of Surgeons 2013(ACS), Washington, D.C., Oct. 2013.
77. Zhu Chengzhan, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, 石川 大地, A Tajima, I Imoto and Mitsuo Shimada :
Hypomethylation of LINE-1 is associated with a poor prognosis after hepatectomy for patients with hepatocellular carcinoma.,
1st International Conference of Federation of Asian Clinical Oncology(FACO), 中国, Sep. 2013.
78. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, 石川 大地, Zhu Chengzhan, A Tajima and I. Imoto :
Genome-wide analysis of aberrant DNA methylation profiling in non-tumor liver tissues of patients with non-B non-C hepatocellular carcinoma,
1st International Conference of Federation of Asian Clinical Oncology(FACO), 中国, Sep. 2013.
79. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, 石川 大地 and Bat-Erdene Batsaikhan :
Prediction of Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy Using Preoperative lens Culinaris Agglutinin-Reactive Fraction of Alpha-Fetoprotein(AFP-L3).,
第5回 日本・モンゴル消化器がんシンポジウム, モンゴル, Sep. 2013.
80. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, 石川 大地 and Bat-Erdene Batsaikhan :
Recent Advancements in Liver Surgery : Assessment of Functional Reserve, Simulation, and Navigation.,
第5回 日本・モンゴル消化器がんシンポジウム, モンゴル, Sep. 2013.
81. 石川 大地, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Shuichi Iwahashi and 山田 眞一郎 :
Ompact of Expression of Twist1 and Bmi1 in Intraductal Papillary Mucinous Neoplasm.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
82. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto and Chie Takasu :
Significance of Stem Cell Markers Expression in Cholangiolocellular Carcinoma.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
83. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Shuichi Iwahashi, 山田 眞一郎 and 石川 大地 :
Impact of Bioelectrical Impedance Analysis in Pancreato-Duodenectomy.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
84. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Shuichi Iwahashi, 山田 眞一郎 and 石川 大地 :
Impact of Bioelectrical Impedance Analysis in Pancreato-Duodenectomy.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
85. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, 山田 眞一郎 and 石川 大地 :
Strategy for Intrahepatic Cholangiocarcinoma: From Cancer Stem Cell to Multidisciplinary.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
86. Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, Yu Saitou, Chie Takasu and 山田 眞一郎 :
Recent Advancements in Liver Surgery: Assessment of Funcional Reserve, Simulation and Navigation.,
International Association of Surgeons, Gastroenterologists and Oncologists 2013(IASGO), ルーマニア, Sep. 2013.
87. Yu Saitou, Mitsuo Shimada, Toru Utsunomiya, Tetsuya Ikemoto, 山田 眞一郎 and Chie Takasu :
The homing effect of adipose-derived stem cells to the injured liver: The shift of stromal cellderived factor 1 expressions.,
The 13th Congress of the Asian Society Of Transplantation 2013(CAST), Kyoto, Sep. 2013.
88. Yusuke Arakawa, Mitsuo Shimada, 石川 大地, 山田 眞一郎, Yu Saitou, Chie Takasu, Shuichi Iwahashi, Mami Kanamoto, Hiroki Mori, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Toru Utsunomiya, Horohiko Sato and Hidenori Miyake :
The gene profile in the spleen under rat small-for-size graft model using cDNA microarray and pathway analaysis.,
The 13th Congress of the Asian Society Of Transplantation 2013(CAST), Kyoto, Sep. 2013.
89. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi and Yu Saitou :
Successfully treated case of liver transplant recipient with donor-specific antibody against human leukocyte antigen.,
The 13th Congress of the Asian Society Of Transplantation 2013(CAST), Kyoto, Sep. 2013.
90. Hiroki Mori, Hiroki Ishibashi, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, 矢田 圭吾 and Mitsuo Shimada :
Risk of carcinogenesis in the biliary epithelium in patients with pancreaticobiliary maljunction through both epigenetic and genetic regulation,
International Surgical Week 2013(ISW), ヘルシンキ, Aug. 2013.
91. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa and Mami Kanamoto :
ABO incompatible living donor liver transplantation for HCV positive recipients.,
International Surgical Week 2013(ISW), ヘルシンキ, Aug. 2013.
92. Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Mami Kanamoto and Shuichi Iwahashi :
Successful management of liver transplant recipient with strongly positive donor-specific antibody against human leukocyte antigen.,
International Surgical Week 2013(ISW), ヘルシンキ, Aug. 2013.
93. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Hiroki Mori, Mami Kanamoto, 山田 眞一郎 and Hidenori Miyake :
Laparoscopic hepatic resection for metastatic liver tumor of colorectal cancer: comparative analysis of short and long term results.,
Society of American Gastrointestinal and Endoscopic Surgeons 2013(SAGES), Baltimore, Apr. 2013.
94. Mami Kanamoto, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Shuichi Iwahashi, 山田 眞一郎, 浅野間 理仁 and 石川 大地 :
Laparoscopic surgery using vessel sealing systmen for giant liver cysts.,
Society of American Gastrointestinal and Endoscopic Surgeons 2013(SAGES), Baltimore, Apr. 2013.
95. Mitsuo Shimada, Shuichi Iwahashi, 山田 眞一郎, Yu Saitou, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Toru Utsunomiya and Hidenori Miyake :
Laparoscopic hepatectomy could be the first choice of treatment in selected patients with hepatocellular.,
Society of American Gastrointestinal and Endoscopic Surgeons 2013(SAGES), Baltimore, Apr. 2013.
96. Tetsuya Ikemoto :
Usefulmess of peripheral regulatory T-cells induced by Notch signaling pathway-driven indoleamine 2,3-dioxygenase positive dendritic cell as a biomarker for the decision for IPMN surgical indications.,
Gastrointestinal Cancers Symposium 2013(ASCO-GI), Jan. 2013.
97. 淺野間 理仁, Mitsuo Shimada, Toru Utsunomiya, Horohiko Sato, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mami Kanamoto, Yusuke Arakawa, Shuichi Iwahashi, 山田 眞一郎 and Hidenori Miyake :
Treatment Strategy for Advanced Biliary Circinomas:Repeat Resection of Biliary Cancers.,
22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists(IASGO2012), Paris, Dec. 2012.
98. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mami Kanamoto, Shuichi Iwahashi, 山田 眞一郎, 淺野間 理仁, 石川 大地, Horohiko Sato and Hidenori Miyake :
Treatment strategy based on the characteristics of non-tumor liver tissues in patients.,
22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists(IASGO2012), Paris, Dec. 2012.
99. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Yusuke Arakawa, Mami Kanamoto, Horohiko Sato and Hidenori Miyake :
Impact of dendritic cell-induced regulatory T cell as a possible novel biomarker for surgical indication of IPMN.,
22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists(IASGO2012), Paris, Dec. 2012.
100. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Yusuke Arakawa, Mami Kanamoto, Shuichi Iwahashi, 山田 眞一郎, 淺野間 理仁 and 石川 大地 :
Recent Advancement of Surgical Treatment Of Liver Cancer.,
22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists(IASGO2012), Paris, Dec. 2012.
101. Mitsuo Shimada, Toru Utsunomiya, Mami Kanamoto, Yusuke Arakawa, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Hidenori Miyake :
A New Anatomical Resection of the Liver Based on hybrid Concept of Portal Perfusion of Anterior Segment and Venous Drainage of Superior Right Hepatic Vein.,
22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists(IASGO2012), Paris, Dec. 2012.
102. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, 杉本 光司, 齋藤 裕 and 山田 眞一郎 :
Molecular Characteristics of Non-Tumor Liver Tissues May Help to Determine Therapeutic Strategy in Patients with Hepatocellular Carcinoma.,
American College Of Surgeons Annual Crinical Congress(ACS2012), Sep. 2012.
103. Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Tomohiko Miyatani, 齋藤 裕, 山田 眞一郎 and Enkhbold Chinbold :
One-Stop Shopping for 3-Dimensional Anatomy of Hepatic Vasculature and Bile Duct with a Special Reference to Biliary Image Reconstruction.,
American College Of Surgeons Annual Crinical Congress(ACS2012), Chicago, Sep. 2012.
104. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Nobuhiro Kurita, Horohiko Sato, Yuji Morine, Tetsuya Ikemoto, Tomohiko Miyatani, 柏原 秀也 and 淺野間 理仁 :
Simultaneous laparoscopic resection of primary colorectal cancer and metastatic liver tumor.,
4th Japanese-Mongolian International Cancer Joint Symposium, ウランバートル, Sep. 2012.
105. 松本 規子, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka and Hidenori Miyake :
Role of CD151 expression in gallbladder carcinoma.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
106. Tomohiko Miyatani, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori and Jun Hanaoka :
Chemotherapeutic regimen to reduce the liver damage by oxaliplatin-based chemotherapy and to enhance conversion in patients with initially unresectable colorectal liver metastases.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
107. 寺奥 大貴, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Mami Kanamoto and Hidenori Miyake :
Active resection for heterochronial triple cholangiocellar carcinomas.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
108. 石川 大地, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto and Hidenori Miyake :
Impact of TJ-137 administration for the prevention of asverse events during chemotherapy in patients with advanced pancreatic cancer patients.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
109. 杉本 光司, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori and Hidenori Miyake :
Usefulness of evaluating functional of the liver using EOB-MRI and indocyanin green fluorescence navigation during operation for safe and curative hepatectomy.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
110. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Jun Hanaoka, Tomohiko Miyatani and Mami Kanamoto :
Impact of human adipose tissue derived regenerative cell for cryopreserved porcine islets.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
111. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, 齋藤 裕 and Hidenori Miyake :
Treatment strategy for advanced biliary carcinomas: Aspecial reference to adjuvant chemotherapy and repeated hepatectomy for intrahepatic recurrence.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
112. Mitsuo Shimada, Toru Utsunomiya, Mami Kanamoto, Tomohiko Miyatani, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Hidenori Miyake :
A new hepatectomy based on a hybrid concept of portal perfusion of anterior segment and venous drainage area of suoerior right hepatic vein.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
113. Hiroki Mori, Hiroki Ishibashi, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hidenori Miyake and Mitsuo Shimada :
Risk of carcinogenesis in the biliary epithelium in patients with pancreaticobiliary maliunction through both epigenetic and genetic pathway.,
10th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2012), Paris, Jul. 2012.
114. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, Tomohiko Miyatani, 齋藤 裕, 山田 眞一郎 and 淺野間 理仁 :
Indoleamine 2, 3-dioxygenase (IDO) and jagged 1 expression on dendrtic cells reflect peripheral regulatory T cells in pancreatic neoplasms.,
Digestive Disease Week (DDW2012), San Diego, May 2012.
115. Hiroki Mori, Hiroki Ishibashi, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, 杉本 光司, 齋藤 裕, 淺野間 理仁, 山田 眞一郎, Hidenori Miyake and Mitsuo Shimada :
Risk of carcinogenesis in the biliary epithelium in patients with pancreaticobiliary maljunction.,
Digestive Disease Week (DDW2012), San Diego, May 2012.
116. Toru Utsunomiya, Mitsuo Shimada, Jun Hanaoka, Mami Kanamoto, Tetsuya Ikemoto, Yuji Morine and Satoru Imura :
Possible utility of MRI using Gd-EOB-DTPA for estimating liver functional reserve.,
Journal of Gastroenterology, Vol.47, No.4, 470-476, Apr. 2012.
(DOI: 10.1007/s00535-011-0513-8,   PubMed: 22170416,   Elsevier: Scopus)
117. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, 齋藤 裕, 浅野間 理仁 and 山田 眞一郎 :
Specific miRNA expression profiles of non-tumor liver tissues predict the risk for multicentric occurrence of hepatocellular carcinoma.,
American Association for Cancer Research (AACR2012), Chicago, Mar. 2012.
118. 吉川 雅登, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto and Hidenori Miyake :
Laparoscope-assisted hepatic resection for gallbladder cancer.,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
119. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 杉本 光司 and Hidenori Miyake :
Laparoscopic hepatic resection for hepatocellular carcinoma: comparative analysis of short and long term results.,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
120. Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka and Hidenori Miyake :
Feasibility of laparoscopic hepatectomy for intrahepatic cholangiocarcinoma.,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2012), San Diego, Mar. 2012.
121. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 岩橋 衆一, 齋藤 裕 and 浅野間 理仁 :
Action of SDF-1/CXCR4 axis in liver metastasis of colorectal cancer.,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2012), San Francisco, Jan. 2012.
122. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) for patients with advanced biliary carcinoma as a postoperative adjuvant chemotherapy.,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2012), San Francisco, Jan. 2012.
123. Mitsuo Shimada, Toru Utsunomiya, Jun Hanaoka, Hiroki Mori, Tetsuya Ikemoto, Satoru Imura, Yuji Morine, Tomohiko Miyatani, Horohiko Sato and Nobuhiro Kurita :
Effect of bevacizmab on sinusoidal injury in patients receiving oxaliplatin-based chemotherapy and liver damage after massive hepatectomy in rats.,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2012), San Francisco, Jan. 2012.
124. 齋藤 裕, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, 山田 眞一郎 and 浅野間 理仁 :
Beneficial effects of adiose-derived stem cells on severe hepatic damage due to hepatectomy and ischemia reperfusion injury in mice.,
21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
125. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
Bevacizumab ameliorates sinusoidal injury after oxaliplatin-based chemotherapy and enhances liver regeneration after hepatectomy.,
21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
126. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 齋藤 裕, 山田 眞一郎, 浅野間 理仁 and Hidenori Miyake :
Application of EOB-MRI as the preoperative simulation for liver surgery: simultaneous evaluation of liver function and volume.,
21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
127. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, 齋藤 裕, 浅野間 理仁, 山田 眞一郎 and Hidenori Miyake :
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.,
21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
(DOI: 10.1007/s00535-009-0164-1,   PubMed: 19997856,   Elsevier: Scopus)
128. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, 齋藤 裕, 浅野間 理仁, 山田 眞一郎 and Hidenori Miyake :
Effects of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) for patients with unresectable biliary carcinoma and its possible usefulness for postoperative adjuvant chemotherapy.,
21st World Congress of the International Association of surgeons, Gastroenterologists and Oncologigts(IASGO2011), Tokyo, Nov. 2011.
129. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, 岩橋 衆一, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
CD44 Expression Can Predict Prognosis of Intrahepatic Cholangiocarcinoma.,
97th Clinical Congress of American college of Srgeons (ACS), San Francisco, Oct. 2011.
130. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕 and 浅野間 理仁 :
Cytoprotective effect of human adipose tissue derived stem cell on porcine islet cells.,
12th Congress of the Asian Society of Transplantation (CAST2011), Seoul, Sep. 2011.
131. 齋藤 裕, Mitsuo Shimada, Toru Utsunomiya, Tetsuya Ikemoto, 山田 眞一郎, Yuji Morine, Satoru Imura, Hiroki Mori, Jun Hanaoka, 杉本 光司 and 浅野間 理仁 :
The possibility of adipose-derived stem cells for an alternative therapy for liver failure.,
12th Congress of the Asian Society of Transplantation (CAST2011), Seoul, Sep. 2011.
132. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, 岩橋 衆一 and 松本 慎一 :
The role of donor specific regulatory T cells expanded by interferon-gamma inducible indoleamine 2,3-dioxygenase(IDO)+ plasmacytoid dendritic cell.,
12th Congress of the Asian Society of Transplantation (CAST2011), Seoul, Sep. 2011.
133. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
Impact of left lobe graft on adult living donor liver transplantation : small-for-size graft is not a risk factor for short and long outcome.,
12th Congress of the Asian Society of Transplantation (CAST2011), Seoul, Sep. 2011.
134. 齋藤 裕, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 杉本 光司, 山田 眞一郎 and 浅野間 理仁 :
Ischemia reperfusion injury enhances SDF1 expressions and hhoming of adipose derived regenerative cells in the liver.,
8th International Smposium on Minimal Residual Cancer (ISMRC2011), Osaka, Sep. 2011.
135. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 杉本 光司, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
Peripheral regulatory Tcell induced by Indoleamine 2,3-dioxygenase as a precise biomarker of pancreatic neoplasms.,
8th International Smposium on Minimal Residual Cancer (ISMRC2011), Osaka, Sep. 2011.
136. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, 齋藤 裕, 山田 眞一郎 and 浅野間 理仁 :
Role of histone deacetylase expression in IHCC: A possible epigenetic regulation of cancer stem cell.,
8th International Smposium on Minimal Residual Cancer (ISMRC2011), Osaka, Sep. 2011.
137. 石川 大地, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕, 浅野間 理仁, Kume Hisae and Sasaki Hajime :
Whey protein isolate,MEIN®, can reduce liver damege early after living donor liver transplantation.,
European Society for Organ Transplantation, glasgow, Sep. 2011.
138. 浅野間 理仁, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕 and 山田 眞一郎 :
Cytoprotective effect of human adipose tissue derived regenerative cell on porcine islet cells.,
European Society for Organ Transplantation, Sep. 2011.
139. Hiroki Mori, Mitsuo Shimada, 齋藤 裕, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, 岩橋 衆一, 浅野間 理仁 and 山田 眞一郎 :
The possibility of adipose-derived regenerative cells for an alternative therapy for liver failure.,
European Society for Organ Transplantation, glasgow, Sep. 2011.
140. Yusuke Arakawa, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕, 浅野間 理仁 and 山田 眞一郎 :
Chance of salvage transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to up-to-7 criteria.,
European Society for Organ Transplantation, glasgow, Sep. 2011.
141. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕, 浅野間 理仁 and 山田 眞一郎 :
Impact of left lobe graft on adult living donor liver transplantation: small-for-size graft is not a risk factor for short and long outcome.,
European Society for Organ Transplantation, glasgow, Sep. 2011.
142. 杉本 光司, 松本 慎一, Tetsuya Ikemoto, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, 岩橋 衆一, 齋藤 裕, 浅野間 理仁, 山田 眞一郎 and Mitsuo Shimada :
The immunological tolerance effects of donor specific regulatory T cells through interferon-gamma inducible indoleamine 2,3-dioxygenase(IDO)+plasmacytoid dendritic cell.,
European Society for Organ Transplantation, Glasgow, Sep. 2011.
143. Mitsuo Shimada, Satoru Imura, Hiroki Mori, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Mami Kanamoto, 岩橋 衆一, 齋藤 裕, 浅野間 理仁, 山田 眞一郎 and Toru Utsunomiya :
Regeneration of caudate lobe in extended left lobe graft including caudate lobe after living donor liver transplantation.,
European Society for Organ Transplantation, glasgow, Sep. 2011.
144. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Hidenori Miyake :
Comparison of short-term outcome and surgical stress response to laparoscopic and open hemihepatectomy.,
International Surgical Week, Yokohama, Aug. 2011.
145. 齋藤 裕, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Mami Kanamoto :
Green Tea Catechins Improve Liver Dysfunction Following Massive Hepatectomy Through Anti-Oxidative and Anti-Inflammatory Activities in Rat.,
Digestive Disease Week, Chicago, May 2011.
146. 山田 眞一郎, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, Mami Kanamoto, 岩橋 衆一, 齋藤 裕 and 浅野間 理仁 :
Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell line.,
102nd American Association for Cancer Research (AACR2011), Orlando, Apr. 2011.
147. Yuji Morine, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, 岩橋 衆一, 齋藤 裕, 山田 眞一郎, 浅野間 理仁 and Mami Kanamoto :
Role of histone deacetylase expression in intrahepatic cholangiocarcinoma.,
102nd American Association for Cancer Research, Orlando, Apr. 2011.
148. Jun Hanaoka, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Shuichi Iwahashi and Yu Saito :
Utility of hybrid sils with minute diameter forceps in cholecystectomy,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2011), テキサス, Mar. 2011.
149. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, Yu Saito, Nobuhiro Kurita and Hidenori Miyake :
Minimal Invasiveness of laparoscopic left hepatic lobectomy : A special referece to systemic inflammatory response syndrome,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2011), テキサス, Mar. 2011.
150. Yu Saito, Mitsuo Shimada, Yuji Morine, Shuichi Iwahashi, Toru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori and Jun Hanaoka :
Role of histone deacetylase expression on regulating cancer stem cells in intrahepatic cholangiocarcinoma,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2011), San Francisco, Jan. 2011.
151. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Yu Saito :
Effect of a histone deacetylase inhibitor on antitumor effect of gemcitabine to focus the gene network of ingenuity pathways analysis,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2011), San Francisco, Jan. 2011.
152. Hiroki Mori, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, Yu Saito and Shinichiro Yamada :
The impact of bevacizumab on liver regeneration following hepatectomy in rats,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2011), San Francisco, Jan. 2011.
153. Mitsuo Shimada, Masanori Nishioka, Jun Hanaoka, Hiroki Mori, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Toru Utsunomiya :
Impact of FOLFOXIRI plus bevacizumab on resectability and survival in patients with initially unresectable liver metastases from colorectal cancer,
Gastrointestinal Cancers Symposium:Science and Multidiscriplinary Management of GI Malignancies (ASCO-GI 2011), San Francisco, Jan. 2011.
154. Michihito Asanoma, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, Yu Saito and Shinichiro Yamada :
Role of regulatory T cell and IDO as a biomarker for pancreatic IPMN,
20th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), エジプト, Oct. 2010.
155. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Yu Saito and Michihito Asanoma :
Histone deacetylase inhibitor enhances anti-tumor effect of gemcitabine on pancreatic cancer and cholangiocarcinoma cell line,
20th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), エジプト, Oct. 2010.
156. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, Yu Saito, Michihito Asanoma and Shinichiro Yamada :
Role of human adipose tissue-derived stem cells in gastroenterological disorders,
20th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), エジプト, Oct. 2010.
157. Shuichi Iwahashi, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Yu Saito :
Systematic anatomical hepatic repatic resection under preceding US-guided glissonean control by thermal ablation,
アジアハイパーサーミア腫瘍学会第5回大会・日本ハイパーサーミア学会第27回大会合同大会, Fukuoka, Sep. 2010.
158. Yu Saito, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka and Shuichi Iwahashi :
The correlation between cancer stem like cells and epigenetic alteration in intrahepatic cholangiocarcinoma,
The 9th International Conference of The Asian Clinical Oncology Society(ACOS2010), Gifu, Aug. 2010.
159. Tetsuya Ikemoto, Mitsuo Shimada, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi, Yu Saito and Shinichiro Yamada :
Indolamine 2,3-deoxygenase (IDO) has influences for the aggressiveness of IPMN through Foxp3+CD4+CD25+Tcell (Treg) in peripheral blood,
The 9th International Conference of The Asian Clinical Oncology Society(ACOS2010), Gifu, Aug. 2010.
160. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi and Yu Saito :
Laparoscopic left liver resection: Technical refinement for standardization of laparoscopic left hepatic lobectomy,
The 9th International Conference of The Asian Clinical Oncology Society(ACOS2010), Gifu, Aug. 2010.
161. Toru Utsunomiya, Mitsuo Shimada, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Shuichi Iwahashi and Yu Saito :
Timing of salvage transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Up-to-7 criteria,
The 9th International Conference of The Asian Clinical Oncology Society(ACOS2010), Gifu, Aug. 2010.
162. Shinichiro Yamada, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Jun Hanaoka, Hiroki Mori, Shuichi Iwahashi, Yu Saito, Yuko Kawata and Hidenori Miyake :
Effect Rikkunshito, a kampo medicine, for gastro-intestinal sympotoms after pylorus-preserving pancreto-duodenectomy (PpPD),
9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2010), ブエノスアイレス, Apr. 2010.
163. Tetsuya Ikemoto, Mitsuo Shimada, Masato Komatu, Toru Utsunomiya, Satoru Imura, Yuji Morine, Hiroki Mori, Jun Hanaoka, Yu Saito and Yuko Kawata :
Effect of humen adipose-tissue derived-mesenchymas stem cell on streptozotocin-induced diabetic nude mice,
9th World Congress of the International Hepato-Pancreato-Biliary Association (IHPBA2010), ブエノスアイレス, Apr. 2010.
164. Satoru Imura, Mitsuo Shimada, Toru Utsunomiya, Yuji Morine, Tetsuya Ikemoto, Jun Hanaoka, Shuichi Iwahashi, Yu Saitou, Nobuhiro Kurita and Hidenori Miyake :
Laparoscopic resection of the left liver Technical refinements for standardization-,
Society of American Gastrointestinal Endoscopic Surgeons (SAGES2010), Washington, D.C., Apr. 2010.

Proceeding of Domestic Conference:

1. Takuya Tokunaga, Yuhei Waki, Hiroki Ishibashi, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
ADSCから分化したSchwann cell-like cellが神経修復へ与える影響に関する基礎的検討,
第23回日本再生医療学会総会, Mar. 2024.
2. Yuhei Waki, Yu Saitou, Tetsuya Ikemoto, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞から分化誘導した肝細胞様細胞の尿素サイクル異常症モデルマウスへの移植効果,
第23回日本再生医療学会総会, Mar. 2024.
3. Yu Saitou, Tetsuya Ikemoto, Yuhei Waki, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
脂肪由来幹細胞から分化誘導した肝細胞様細胞の免疫原性獲得に関する研究,
第23回日本再生医療学会総会, Mar. 2024.
4. Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
再生医療を用いた新たな膵β細胞(insulin producing cell:IPC)移植戦略の樹立に関する研究,
第23回日本再生医療学会総会, Mar. 2024.
5. Hiroki Teraoku, Yuhei Waki, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
腫瘍関連マクロファージ(TAM)とのcrosstalkを介したLenvatinib耐性肝細胞 癌における悪性度獲得機序,
第56回制癌剤適応研究会, Feb. 2024.
6. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki and Mitsuo Shimada :
Atezolizmab+Bevacizumab療法ならびにTremelimumab+Durvalumab療法により縮小が得られ肝切除を施行し得たVp4を伴う進行肝細胞癌の一例,
第29回日本肝がん分子標的治療研究会, Jan. 2024.
7. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki and Mitsuo Shimada :
切除可能境界膵癌における集学的治療の意義,
第120回日本消化器病学会四国支部例会, Dec. 2023.
8. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
腹腔鏡下肝切除におけるPitfall -心房細動アブレーション後医原性心房中隔欠損を介した奇異性塞栓症-,
第36回日本内視鏡外科学会総会, Dec. 2023.
9. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
最大腫瘍径×個数を用いた新たなresectabilityと治療戦略の提唱,
第45回日本肝臓学会西部会, Dec. 2023.
10. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
肝内胆管癌における新たな予後予測 - MRI拡散強調画像と腫瘍浸潤リンパ球 –,
第45回日本肝臓学会西部会, Dec. 2023.
11. Yuuma Wada, Chie Takasu, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Hiroki Teraoku, Kouzou Yoshikawa, Takuya Tokunaga, Toshihiro Nakao, Masaaki Nishi, Hideya Kashihara, Toshiaki Yoshimoto and Mitsuo Shimada :
肝細胞癌におけるエクソソームmiRNAを介したLenvatinib耐性機序の検討,
第34回日本消化器癌発生学会総会, Nov. 2023.
12. Yuhei Waki, Yuji Morine, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto and Mitsuo Shimada :
肝細胞癌微小環境におけるNrf2シグナルを介した癌細胞とTAMの相互作用,
第34回日本消化器癌発生学会総会, Nov. 2023.
13. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and Mitsuo Shimada :
大建中湯(TU-100)のNASH発癌抑制効果に関する検討,
第34回日本消化器癌発生学会総会, Nov. 2023.
14. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
80歳以上の高齢者膵癌に対する膵頭十二指腸切除の治療成績,
第85回日本臨床外科学会総会, Nov. 2023.
15. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and Mitsuo Shimada :
大腸癌多発肝転移における最大腫瘍径×個数を用いた肝切除基準と集学的治療方針の提唱,
第85回日本臨床外科学会総会, Nov. 2023.
16. Yu Saitou, Tetsuya Ikemoto and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞を用いた新たな肝細胞様細胞移植の樹立にむけて,
JDDW 2023, Nov. 2023.
17. Yuhei Waki, Yuji Morine, Takayuki Noma, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto and Mitsuo Shimada :
微小環境におけるエクソソームを介した薬剤肝細胞癌の悪性度増強と耐性機序の解明,
第61回日本癌治療学会学術集会, Oct. 2023.
18. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
再発肝細胞癌に対する肝切除成績,
第61回日本癌治療学会学術集会, Oct. 2023.
19. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
膵・胆管合流異常における胆道上皮PD-L1発現,
第46回日本膵・胆管合流異常研究会, Sep. 2023.
20. Hiroki Teraoku, Yu Saitou, 杉本 真樹, Yuji Morine, Shin-ichiro Yamada, Tetsuya Ikemoto and Mitsuo Shimada :
胆道手術における3D胆道造影Extended realityによる手術支援,
第17回肝癌治療ナビゲーション研究会, Aug. 2023.
21. Yu Saitou, 杉本 真樹, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
肝胆膵手術支援の新展開-Extended reality・ホログラム・メタバース-,
第50回日本膵切研究会, Aug. 2023.
22. Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
症例,
第59回日本肝癌研究会, Jul. 2023.
23. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
肝細胞癌における微小環境クロストークによるLenvatinib耐性機序の検討,
第59回日本肝癌研究会, Jul. 2023.
24. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Yuhei Waki, Tetsuya Ikemoto and Mitsuo Shimada :
肉眼的門脈浸潤を伴う進行肝細胞癌の治療戦略,
第59回日本肝癌研究会, Jul. 2023.
25. Yuhei Waki, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Takayuki Noma, Tetsuya Ikemoto and Mitsuo Shimada :
内科的治療後再発・遺残肝細胞に対するRescue肝切除の意義,
第78回日本消化器外科学会総会, Jul. 2023.
26. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki and Hiroki Teraoku :
徳島大学病院全体と消化器・移植外科のFRT回避に係る連携とOODAループ,
第78回日本消化器外科学会総会, Jul. 2023.
27. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku, Takayuki Noma and Mitsuo Shimada :
EOBによる肝予備能評価と最大腫瘍径×個数を用いた肝切除限界の提唱,
第78回日本消化器外科学会総会, Jul. 2023.
28. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
高齢者膵癌に対する膵頭十二指腸切除術の適応と限界,
第78回日本消化器外科学会総会, Jul. 2023.
29. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Sonoko Yasui-Yamada, Hiroshi Sakaue, 鎌田 基夢, Tetsuya Matsuura and Mitsuo Shimada :
肥満を有する肝細胞癌患者に対する術前栄養運動介入の有用性 - ERAS導入による手術成績の向上 –,
第78回日本消化器外科学会総会, Jul. 2023.
30. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki, Yuhei Waki, Tetsuya Ikemoto and Mitsuo Shimada :
肉眼的門脈浸潤を伴う進行肝細胞癌の治療戦略,
第78回日本消化器外科学会総会, Jul. 2023.
31. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto, Sonoko Yasui-Yamada, Hiroshi Sakaue, 鎌田 基夢, Tetsuya Matsuura and Mitsuo Shimada :
肥満を有する肝細胞癌患者に対する術前栄養運動介入の有用性-ERAS導入による手術成績の向上 –,
日本外科代謝栄養学会第60回学術集会, Jul. 2023.
32. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, 仲須 千春 and Mitsuo Shimada :
PD-L1 expression of biliary epithelium in pancreaticobiliary maljunction,
第35回日本肝胆膵外科学会学術集会, Jun. 2023.
33. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and Mitsuo Shimada :
New strategy for CRLM using Maximum Diameter x Number: MDN,
第35回日本肝胆膵外科学会学術集会, Jun. 2023.
34. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto, Shin-ichiro Yamada, 西 麻希, Hiroshi Sakaue, 鎌田 基夢, Tetsuya Matsuura and Mitsuo Shimada :
Preoperative weight loss program for high body mass index patients undergoing liver resection for hepatocellular carcinoma - Surgical outcomes of ERAS protocol,
第35回日本肝胆膵外科学会学術集会, Jun. 2023.
35. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki and Hiroki Teraoku :
Establishment of investigator initiated clinical trial as a future cell transplantation for to complement existing transplantations,
第35回日本肝胆膵外科学会学術集会, Jun. 2023.
36. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki, Yuhei Waki, Tetsuya Ikemoto and Mitsuo Shimada :
Reconsideration of indication of hepatic for advanced hepatocellular carcinoma and significance of conversion surgery,
第35回日本肝胆膵外科学会学術集会, Jun. 2023.
37. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
肝細胞癌におけるNrf2/VEGFシグナルを介したTumor-associated macrophage (TAM)との相互作用,
第44回癌免疫外科研究会, Jun. 2023.
38. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
術前の心構え「AWA spirits」に基づいたtraining systemによる肝胆膵外科の若手教育,
日本消化器病学会四国支部第119回例会, Jun. 2023.
39. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
StageIII/IVa肝細胞癌におけるMRI拡散強調画像ADC値とTumor infiltrative lymphocyte (TIL),
第59回日本肝臓学会総会, Jun. 2023.
40. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞を用いた新たな肝細胞様細胞移植の樹立にむけて,
第59回日本肝臓学会総会, Jun. 2023.
41. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
高齢者に対する肝胆膵手術におけるFrailtyの意義に関する検討,
第48回日本外科系連合学会学術集会, Jun. 2023.
42. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌における至適肝切除適応の再考とConversion surgeryの意義,
第48回日本外科系連合学会学術集会, Jun. 2023.
43. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Yu Saitou, Shin-ichiro Yamada and Hiroki Teraoku :
徳島大学病院における医療安全管理上の患者アドボカシーの実情と展望,
第48回日本外科系連合学会学術集会, Jun. 2023.
44. Hiroki Mori, Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and Takayuki Noma :
EOB予備能評価に基づいた至適肝切除,
第123回日本外科学会定期学術集会, Apr. 2023.
45. Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
再生医療を用いたβ細胞補填治療法に関するFIH試験樹立に向けて,
第109回日本消化器病学会総会, Apr. 2023.
46. Hiroki Mori, Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and Takayuki Noma :
EOB予備能評価に基づいた至適肝切除,
第123回日本外科学会定期学術集会, Apr. 2023.
47. Takayuki Noma, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
再発肝細胞癌に対する肝切除の意義,
第123回日本外科学会定期学術集会, Apr. 2023.
48. Hiroki Teraoku, Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Sonoko Yasui-Yamada, 西 麻希, Hiroshi Sakaue, 鎌田 基夢, Tetsuya Matsuura and Mitsuo Shimada :
肝細胞癌における肥満患者への術前栄養運動介入の有用性,
第123回日本外科学会定期学術集会, Apr. 2023.
49. Yuhei Waki, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and 仲須 千春 :
Lenvatinib耐性肝細胞癌における癌微小環境を介した悪性度獲得機序の解明,
第123回日本外科学会定期学術集会, Apr. 2023.
50. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Yuhei Waki, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
再生医療によるインスリン産生細胞自家移植戦略は1型糖尿病治療を変える,
第123回日本外科学会定期学術集会, Apr. 2023.
51. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Yuhei Waki, Hiroki Teraoku and 仲須 千春 :
EOBによる肝予備能評価と最大腫瘍径×個数を用いた肝切除限界の提唱,
第123回日本外科学会定期学術集会, Apr. 2023.
52. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Takuya Tokunaga, Shin-ichiro Yamada, Hiroki Teraoku, Takashi Iwata and Mitsuo Shimada :
消化器外科ナビゲーションの新展開 -Extended reality・ホログラム・メ タバース –,
第123回日本外科学会定期学術集会, Apr. 2023.
53. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌における至適肝切除適応の再考とConversion surgeryの意義,
第123回日本外科学会定期学術集会, Apr. 2023.
54. Yuhei Waki, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
ADSCから分化したinsulin producing cell移植時の自己免疫による影響に関する検討,
第22回日本再生医療学会総会, Mar. 2023.
55. Yu Saitou, 陳 述海, Yuhei Waki, Tetsuya Ikemoto, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞を用いた新たな肝細胞様細胞移植の樹立にむけて,
第22回日本再生医療学会総会, Mar. 2023.
56. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Yuhei Waki, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
間葉系幹細胞を用いた新たなβ細胞補填治療法樹立に向けて,
第22回日本再生医療学会総会, Mar. 2023.
57. Yuhei Waki, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
再生医療によって作成されたinsulin producing cell移植後の自己免疫による影響に関する基礎的検討,
第50回日本膵・膵島移植学会学術集会, Mar. 2023.
58. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Yuhei Waki, Hiroki Teraoku, Yuuma Wada, Shin-ichiro Yamada and Yuji Morine :
再生医療を用いたβ細胞補填治療法に関する膵島移植とのクロストーク,
第50回日本膵・膵島移植学会学術集会, Mar. 2023.
59. Hiroki Teraoku, Yuhei Waki, 仲須 千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
Lenvatinib耐性肝細胞癌におけるNrf2を介した悪性度上昇と薬剤耐性獲得機序の検討,
第55回制癌剤適応研究会, Feb. 2023.
60. Yuhei Waki, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
Lenvatinib耐性肝細胞癌における癌微小環境を介した悪性度獲得と薬剤耐性獲得機序の解明,
第27回日本肝がん分子標的治療研究会, Jan. 2023.
61. Shin-ichiro Yamada, Yuji Morine, Yu Saitou, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
肝細胞癌BCLC intermediate stageにおけるMaximum tumor diameter × number の意義,
第27回日本肝がん分子標的治療研究会, Jan. 2023.
62. Hiroki Mori, Yuji Morine, Hiroki Ishibashi, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Shoko Yamashita, Koichi Tsuneyama and Mitsuo Shimada :
慢性炎症状態の膵・胆管合流異常におけるNLRP3活性化を介した腫瘍微小環境と発癌に関する検討,
第33回日本消化器癌発生学会総会, Nov. 2022.
63. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Yuhei Waki, Takayuki Noma and Mitsuo Shimada :
大腸癌肝転移におけるoncological/liver functional resectabilityの定義と集学的治療戦略,
第84回日本臨床外科学会総会, Nov. 2022.
64. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する外科切除成績とConversion surgeryの意義,
第84回日本臨床外科学会総会, Nov. 2022.
65. Tetsuya Ikemoto, Mitsuo Shimada, Shin-ichiro Yamada, Hiroki Teraoku, Yu Saitou and Yuji Morine :
de novo B型肝炎管理体制構築に向けた取り組み,
第84回日本臨床外科学会総会, Nov. 2022.
66. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Sonoko Yasui-Yamada, 西 麻希, Hiroshi Sakaue, 鎌田 基夢, Tetsuya Matsuura and Mitsuo Shimada :
肥満を有する肝細胞癌患者に対する術前栄養運動介入の有用性,
第118回日本消化器病学会四国支部例会, Nov. 2022.
67. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, 仲須 千春, 髙橋 叡, Takayuki Noma and Mitsuo Shimada :
StageIII/IV肝細胞癌における拡散強調画像ADC値の意義,
第33回日本消化器癌発生学会総会, Nov. 2022.
68. Chie Takasu, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
大腸癌肝転移における発育形式と予後に関する検討,
第84回日本臨床外科学会総会, Nov. 2022.
69. Chie Takasu, 仲須 千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Yuhei Waki and Mitsuo Shimada :
Nrf2を基軸とした癌微小環境クロストークによる 肝細胞癌Lenvatinib耐性機序解明に関する研究,
第33回日本消化器癌発生学会総会, Nov. 2022.
70. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
肝細胞癌におけるlymphocyte/C-reactive protein ratio(LCR)の有用性,
JDDW 2022, Oct. 2022.
71. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
高齢者膵癌切除例におけるフレイルの影響に関する検討,
JDDW 2022, Oct. 2022.
72. 仲須 千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Yuhei Waki, Hiroki Teraoku and Mitsuo Shimada :
肝細胞癌におけるNrf2に着目したレンバチニブ耐性獲得機序についての検討,
第60回日本癌治療学会学術集会, Oct. 2022.
73. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, 仲須 千春 and Mitsuo Shimada :
肝癌微小環境におけるNrf2/VEGFシグナルを介した肝癌細胞とTAMの相互作用,
第60回日本癌治療学会学術集会, Oct. 2022.
74. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
高齢者膵癌切除例の予後におけるフレイルの影響に関する検討,
第60回日本癌治療学会学術集会, Oct. 2022.
75. Tetsuya Ikemoto, Takuya Tokunaga, Yuhei Waki, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Yuji Morine and Mitsuo Shimada :
Schwann-like cell分化誘導による末梢神経損傷修復に関する基礎的検討,
第60回日本癌治療学会学術集会, Oct. 2022.
76. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する肝切除の意義,
第60回日本癌治療学会学術集会, Oct. 2022.
77. Yuhei Waki, Yu Saitou, Tetsuya Ikemoto, 陳 術海, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞から肝細胞様細胞の創出-肝不全・代謝性肝疾患に対する肝移植から細胞治療へ,
第58回日本移植学会総会, Oct. 2022.
78. Yu Saitou, Mitsuo Shimada, Hiroki Teraoku, Shin-ichiro Yamada, Tetsuya Ikemoto and Yuji Morine :
脳死肝移植ドナー不足解消にむけての普及啓発活動 - 医療系学生に対するドナーアクション(命の授業)の必要性 –,
第58回日本移植学会総会, Oct. 2022.
79. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
再生医療を用いた移植治療確立へ向けた戦略∼新たなβ細胞補充治療法,
第58回日本移植学会総会, Oct. 2022.
80. Hiroki Mori, Yuji Morine, Hiroki Ishibashi, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Shoko Yamashita, Koichi Tsuneyama and Mitsuo Shimada :
慢性炎症化下の膵・胆管合流異常におけるNLRP3活性化を介した腫瘍微小環境と発癌に関する検討,
第45回日本膵・胆管合流異常研究会, Sep. 2022.
81. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
肝細胞癌腫瘍微小環境におけるNrf2/VEGFシグナルを介した癌細胞とTAMの相互作用,
第81回日本癌学会学術総会, Sep. 2022.
82. Takayuki Noma, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
再発膵癌に対する残膵切除の治療成績,
第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
83. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Takayuki Noma and Mitsuo Shimada :
大腸癌肝転移におけるresectabilityの定義と集学的治療戦略,
第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
84. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
術中ホログラム胆道造影を駆使した胆道手術支援,
第97回中国四国外科学会総会/第27回中国四国内視鏡外科研究会, Sep. 2022.
85. Yu Saitou, 杉本 真樹, Yuji Morine, Hiroki Teraoku, Shin-ichiro Yamada, Tetsuya Ikemoto and Mitsuo Shimada :
術中ホログラム胆道造影を駆使した胆道手術支援,
第16回肝癌治療ナビゲーション研究会, Sep. 2022.
86. Tetsuya Ikemoto :
医療安全について-培ってきたもの,これから培っていくもの-,
第265回徳島医学会学術集会, Jul. 2022.
87. 仲須 千春, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and 沖川 昌平 :
MRI拡散強調画像から見たミラノ基準内肝細胞癌の予後予測に関する検討,
第77回日本消化器外科学会総会, Jul. 2022.
88. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
膵癌残膵再発に対する残膵切除の治療成績,
第77回日本消化器外科学会総会, Jul. 2022.
89. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Toshiaki Yoshimoto, 西 麻希, Hiroshi Sakaue and Mitsuo Shimada :
肥満を有する肝細胞癌患者に対する術前栄養運動介入の有用性,
第77回日本消化器外科学会総会, Jul. 2022.
90. Tetsuya Ikemoto, Yu Saitou, Mitsuo Shimada, 沖川 昌平, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
再生医療を用いた細胞移植治療確立へ向けた戦略∼移植外科医・レシピエント双方の負担軽減という視点から,
第77回日本消化器外科学会総会, Jul. 2022.
91. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
大腸癌肝転移におけるoncological/liver functional resectabilityの定義とBRに対する集学的治療戦略,
第77回日本消化器外科学会総会, Jul. 2022.
92. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する肝切除の意義,
第77回日本消化器外科学会総会, Jul. 2022.
93. Chie Takasu, 仲須 千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Yasuhiro Hamada, 沖川 昌平 and Mitsuo Shimada :
肝細胞癌におけるmiRNA-132, 142-5pを介したLenvatinib耐性機序の検討,
第77回日本消化器外科学会総会, Jul. 2022.
94. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku and Mitsuo Shimada :
肝細胞癌におけるSorafenib/Lenvatinib耐性機序の検討,
第26回日本肝がん分子標的治療研究会, Jun. 2022.
95. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, 宮崎 克己, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する外科切除成績とConversion surgeryの意義,
第26回日本肝がん分子標的治療研究会, Jun. 2022.
96. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する肝切除を中心とした治療戦略,
第31回日本癌病態治療研究会, Jun. 2022.
97. Yu Saitou, Yuji Morine, Shin-ichiro Yamada, Hiroki Teraoku, 宮崎 克己, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する外科切除成績とConversion surgeryの意義,
第117回日本消化器病学会四国支部例会, Jun. 2022.
98. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Yu Saitou, Shin-ichiro Yamada and Hiroki Teraoku :
消化器・移植外科から発信する手術室医療安全,
第47回日本外科系連合学会学術集会, Jun. 2022.
99. Hiroki Teraoku, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, 沖川 昌平, Tetsuya Ikemoto and Mitsuo Shimada :
Associations between the ADC values based on MRI diffusion-weighted images and tumor-infiltrative lymphocytes in Stage III / IV hepatocellular carcinoma,
第34回日本肝胆膵外科学会・学術集会, Jun. 2022.
100. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou and Hiroki Teraoku :
Impact of frailty on resected pancreatic cancer in elderly patients,
第34回日本肝胆膵外科学会・学術集会, Jun. 2022.
101. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Masaaki Nishi, Hiroshi Sakaue and Mitsuo Shimada :
Weight loss program for high body mass index patients undergoing liver resection for hepatocellular carcinoma,
第34回日本肝胆膵外科学会・学術集会, Jun. 2022.
102. Tetsuya Ikemoto, Yu Saitou, Mitsuo Shimada, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
Establishment of investigator initiated clinical trial for insulin producing cells from ADSC with Tokushima protocol to complement pancreas/islet transplantation.,
第34回日本肝胆膵外科学会・学術集会, Jun. 2022.
103. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
Role of surgical resection for advanced hepatocellular carcinoma focused on conversion surgery in MTA era,
第34回日本肝胆膵外科学会・学術集会, Jun. 2022.
104. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Takuya Tokunaga, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
術中ホログラム胆道造影を駆使した胆道手術支援,
第31回日本コンピュータ外科学会大会, Jun. 2022.
105. Hiroki Teraoku, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, 沖川 昌平, Tetsuya Ikemoto and Mitsuo Shimada :
Significance of the ADC values based on MRI DWI in Stage / HCC,
第67回国際外科学会日本部会総会, Jun. 2022.
106. Chie Takasu, 仲須 千春, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, 沖川 昌平 and Mitsuo Shimada :
肝細胞癌におけるmiRNA-X,Yを介したLenvatinib耐性機序の検討,
第26回日本肝がん分子標的治療研究会, Jun. 2022.
107. Maki Hirata, Tetsuya Ikemoto, Kazunori Tokuda, Shohei Okikawa, 竹島 雅之, Fumiki Morimatsu and Mitsuo Shimada :
糖尿病モデルマイクロミニブタの確立,
第69回日本実験動物学会総会, May 2022.
108. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
症例,
第58回日本肝癌研究会, May 2022.
109. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, 沖川 昌平 and Mitsuo Shimada :
大腸癌肝転移におけるoncological/liver functional resectabilityの定義とBRに対する集学的治療戦略,
第58回日本肝癌研究会, May 2022.
110. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する肝切除の意義,
第58回日本肝癌研究会, May 2022.
111. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
術中ホログラム胆道造影を駆使した肝胆道手術支援,
第58回日本肝癌研究会, May 2022.
112. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Tetsuya Ikemoto and Mitsuo Shimada :
再発肝細胞癌に対する肝切除の意義,
第58回日本肝癌研究会, May 2022.
113. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, 沖川 昌平 and 山下 祥子 :
高齢者膵癌切除例におけるフレイルの影響に関する検討,
第108回日本消化器病学会総会, Apr. 2022.
114. 髙橋 叡, Hiroki Teraoku, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, 沖川 昌平, Tetsuya Ikemoto and Mitsuo Shimada :
Stage III/IV 肝細胞癌におけるMRI拡散強調画像をもとにしたADC値の有用性に関する検討,
第122回日本外科学会定期学術集会, Apr. 2022.
115. Hiroki Teraoku, Yuji Morine, Yu Saitou, Shin-ichiro Yamada, 沖川 昌平, Tetsuya Ikemoto and Mitsuo Shimada :
Borderline resectableに着目した切除可能分類に基づく膵癌治療成績に関する検討,
第122回日本外科学会定期学術集会, Apr. 2022.
116. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, 沖川 昌平 and Mitsuo Shimada :
膵癌切除例における早期再発の危険因子に関する検討,
第122回日本外科学会定期学術集会, Apr. 2022.
117. 荒川 悠佑, Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
切除可能膵癌における術後予後予測因子としてのCRP・アルブミン比(CAR)の有用性,
第122回日本外科学会定期学術集会, Apr. 2022.
118. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, 宮崎 克己 and Mitsuo Shimada :
術中ホログラム胆道造影を駆使した胆道手術支援,
第122回日本外科学会定期学術集会, Apr. 2022.
119. Tetsuya Ikemoto, Mitsuo Shimada, Yu Saitou, 沖川 昌平, Hiroki Teraoku, Shin-ichiro Yamada and Yuji Morine :
自己脂肪から作成したインスリン産生細胞自家移植が拓く再生医療の未来,
第122回日本外科学会定期学術集会, Apr. 2022.
120. Chie Takasu, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, 沖川 昌平 and Mitsuo Shimada :
間葉系幹細胞から肝細胞様細胞の誘導におけるNrf2の働きに関する検討,
第122回日本外科学会定期学術集会, Apr. 2022.
121. Tetsuya Ikemoto, Takuya Tokunaga, Yu Saitou, Shohei Okikawa, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞から分化誘導したSchwann-like cellに関する研究,
第21回日本再生医療学会総会, Mar. 2022.
122. Shohei Okikawa, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, NAKASU Chiharu and Mitsuo Shimada :
VEGF阻害はTAMの機能を減弱させる,
第25回日本肝がん分子標的治療研究会, Jan. 2022.
123. Hiroki Teraoku, Yuji Morine, Shin-ichiro Yamada, Tetsuya Ikemoto, Yu Saitou and Mitsuo Shimada :
腹腔鏡下膵体尾部切除の手術手技と定型化,
第34回日本内視鏡外科学会総会, Dec. 2021.
124. Chie Takasu, Gao Luping, Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shohei Okikawa, Katsuki Miyazaki and Mitsuo Shimada :
Nrf2を介した微小環境クロストークによる肝細胞癌薬剤耐性機序解明に関する研究,
第32回日本消化器癌発生学会総会, Nov. 2021.
125. Chie Takasu, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Mitsuo Shimada :
大腸癌肝転移における免疫逃避機構の働き,
第83回日本臨床外科学会総会, Nov. 2021.
126. Shohei Okikawa, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Katsuki Miyazaki, NAKASU Chiharu and Mitsuo Shimada :
VEGF阻害はTAMの悪性度を減じる,
第32回日本消化器癌発生学会総会, Nov. 2021.
127. Hiroki Teraoku, Gao Luping, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
肝細胞癌におけるNrf2-PINK-1axisを介したLenvatinib耐性機序の検討,
第32回日本消化器癌発生学会総会, Nov. 2021.
128. Shin-ichiro Yamada, Gao Luping, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shohei Okikawa, Katsuki Miyazaki and Mitsuo Shimada :
ソラフェニブ耐性肝細胞癌の腫瘍微小環境形成におけるBAFF/BAFF受容体の役割,
第32回日本消化器癌発生学会総会, Nov. 2021.
129. Shin-ichiro Yamada, Gao Luping, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shohei Okikawa and Mitsuo Shimada :
肝細胞癌におけるソラフェニブ耐性獲得機序に関する検討,
第32回日本消化器癌発生学会総会, Nov. 2021.
130. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Takuya Tokunaga, Shin-ichiro Yamada, Hiroki Teraoku, Takashi Iwata and Mitsuo Shimada :
消化器外科におけるホログラム次世代手術支援,
第30回日本コンピュータ外科学会大会, Nov. 2021.
131. Hiroki Teraoku, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
One stop shop を目指したEOB-MRIによる部分肝機能評価,切除限界予測と腫瘍悪性度の評価に関する検討,
第116回日本消化器病学会四国支部例会, Nov. 2021.
132. Hiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada and Mitsuo Shimada :
再発膵癌に対する残膵切除の治療成績,
第83回日本臨床外科学会総会, Nov. 2021.
133. Yu Saitou, 杉本 真樹, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
Extended reality(VR・AR・MR)を駆使した手術ナビゲーション,
第83回日本臨床外科学会総会, Nov. 2021.
134. Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
地方から世界に通用する一流の外科医を目指した取り組み,
第83回日本臨床外科学会総会, Nov. 2021.
135. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki, Tetsuya Ikemoto and Mitsuo Shimada :
進行肝細胞癌に対する外科切除成績とConversion surgeryの意義,
第83回日本臨床外科学会総会, Nov. 2021.
136. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Yu Saitou, Shin-ichiro Yamada and Hiroki Teraoku :
外科医をも守る消化器・移植外科から発信する手術室医療安全,
第83回日本臨床外科学会総会, Nov. 2021.
137. Shoko Yamashita, Yuji Morine, Hiroki Ishibashi, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yu Saitou, Shin-ichiro Yamada, Koichi Tsuneyama and Mitsuo Shimada :
膵・胆管合流異常におけるNLRP3を介した腫瘍微小環境と発癌に関する検討,
第57回日本胆道学会学術集会, Oct. 2021.
138. Shohei Okikawa, Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
DWI-MRIによる進行胆嚢癌の腫瘍悪性度評価,
第57回日本胆道学会学術集会, Oct. 2021.
139. Shin-ichiro Yamada, Katsuki Miyazaki, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Shohei Okikawa, Shoko Yamashita and Mitsuo Shimada :
肝内胆管癌予後規定因子としての腫瘍浸潤リンパ球の意義,
第57回日本胆道学会学術集会, Oct. 2021.
140. Shohei Okikawa, Yuji Morine, Shin-ichiro Yamada, Tetsuya Ikemoto and Mitsuo Shimada :
VEGF inhibition reduce TAM's malignant potential,
第80回日本癌学会学術総会, Sep. 2021.
141. Shin-ichiro Yamada, Gao Luping, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Shohei Okikawa, Shoko Yamashita, Katsuki Miyazaki and Mitsuo Shimada :
The role of BAFF/BAFF receptor in microenvironment of sorafenib resistant he patocellular carcinoma,
第80回日本癌学会学術総会, Sep. 2021.
142. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
生体肝移植術後短期長期成績に関する検討,
第57回日本移植学会総会, Sep. 2021.
143. Hiroki Teraoku, Yu Saitou, Tetsuya Ikemoto, Katsuki Miyazaki, Shin-ichiro Yamada, Yuji Morine, Masato Miyake, Seiichi Oyadomari and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞を基にした機能的肝細胞様細胞の分化誘導,
第57回日本移植学会総会, Sep. 2021.
144. Tetsuya Ikemoto, Yu Saitou, Katsuki Miyazaki, Shohei Okikawa, Hiroki Teraoku, Shin-ichiro Yamada, Yuji Morine and Mitsuo Shimada :
再生医療を用いたインスリン産生細胞自家移植による1型糖尿病根治治療確立へ向けた戦略,
第57回日本移植学会総会, Sep. 2021.
145. Shin-ichiro Yamada, Yu Saitou, Yuji Morine, Tetsuya Ikemoto, Hiroki Teraoku, 杉本 真樹 and Mitsuo Shimada :
Extended reality(VR・AR・MR)を駆使した手術ナビゲーション-マイクロ波手術デバイスAcrosurg®使用経験も含めて-,
第15回肝がんナビゲーション研究会, Sep. 2021.
146. Yu Saitou, Tetsuya Ikemoto, Katsuki Miyazaki, Kazunori Tokuda, Shin-ichiro Yamada, Satoru Imura, Yuji Morine, Masato Miyake, Seiichi Oyadomari and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞から肝細胞様細胞の創出-肝不全・代謝性肝疾患に対する肝移植から細胞治療へ-,
第263回徳島医学会学術集会(令和3年度夏期), Aug. 2021.
147. Shin-ichiro Yamada, Gao Luping, Yuji Morine, Katsuki Miyazaki, Kazunori Tokuda, Shohei Okikawa, Yu Saitou, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
ソラフェニブ耐性肝細胞癌の腫瘍微小環境形成におけるBAFF/BAFF受容体の役割,
第57回日本肝癌研究会, Jul. 2021.
148. Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
DAA治療後SVR症例は発癌Potentialが高く進行病期に関与する,
第57回日本肝癌研究会, Jul. 2021.
149. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
進行肝細胞癌集学的治療における外科切除の役割:Conversion Surgery成績も含めて,
第57回日本肝癌研究会, Jul. 2021.
150. TAKAHASHI Akira, Shin-ichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Katsuki Miyazaki and Mitsuo Shimada :
DWI-MRIによる進行胆嚢癌の腫瘍悪性度評価,
第76回日本消化器外科学会総, Jul. 2021.
151. NAKASU Chiharu, Tetsuya Ikemoto, Takuya Tokunaga, Katsuki Miyazaki, Kazunori Tokuda, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞からSchwann-like cellの効果的分化誘導方法の研究,
第76回日本消化器外科学会総会, Jul. 2021.
152. Shoko Yamashita, Yuji Morine, Hiroki Ishibashi, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yu Saitou, Shin-ichiro Yamada, Koichi Tsuneyama and Mitsuo Shimada :
膵・胆管合流異常におけるNLRP3活性化と発癌に関する検討,
第76回日本消化器外科学会総会, Jul. 2021.
153. Katsuki Miyazaki, Shin-ichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shoko Yamashita, Takeshi Oya, Koichi Tsuneyama and Mitsuo Shimada :
肝内胆管癌予後規定因子としての腫瘍浸潤リンパ球の意義,
第76回日本消化器外科学会総会, Jul. 2021.
154. Kazunori Tokuda, Yuji Morine, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
肝細胞癌の腫瘍微小環境におけるOsteopontinを介したCAF-TAM interactionについての検討,
第76回日本消化器外科学会総会, Jul. 2021.
155. Yuuma Wada, Yuji Morine, Yu Saitou, Satoru Imura, Tetsuya Ikemoto, Masaaki Nishi, Shin-ichiro Yamada, Kazunori Tokuda, Hiroki Teraoku and Mitsuo Shimada :
癌微小環境における大建中湯の癌細胞増殖抑制効果,
第76回日本消化器外科学会総会, Jul. 2021.
156. Shin-ichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Shoko Yamashita, Katsuki Miyazaki and Mitsuo Shimada :
高齢者に対する肝胆膵手術におけるFrailtyの意義に関する検討,
第76回日本消化器外科学会総会, Jul. 2021.
157. Yu Saitou, Maki Sugimoto, Yuji Morine, Tetsuya Ikemoto, Takuya Tokunaga, Hiroki Teraoku, Katsuki Miyazaki, Takashi Iwata and Mitsuo Shimada :
Navigation of rectal and hepatobiliary pancreatic surgery with intraoperative hologram,
第76回日本消化器外科学会総会, Jul. 2021.
158. Tetsuya Ikemoto, Kazunori Tokuda, Yu Saitou, Katsuki Miyazaki, Hiroki Teraoku, Shohei Okikawa, Shin-ichiro Yamada, Satoru Imura and Yuji Morine :
消化器外科領域の幹細胞トランスレーショナルリサーチにおける医工連携,
第76回日本消化器外科学会総会, Jul. 2021.
159. Hiroki Teraoku, Yuji Morine, Shin-ichiro Yamada, Katsuki Miyazaki, Yu Saitou, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
両葉多発大腸癌肝転移に対する肝切除適応基準とConversion Surgery,
第76回日本消化器外科学会総会, Jul. 2021.
160. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku, Katsuki Miyazaki, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
進行肝細胞癌集学的治療における外科切除の役割:Conversion Surgery成績も含めて,
第76回日本消化器外科学会総会, Jul. 2021.
161. Shin-ichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saitou, Hiroki Teraoku, Shoko Yamashita, Katsuki Miyazaki and Mitsuo Shimada :
高齢者に対する肝胆膵手術におけるFrailtyの意義に関する検討,
第115回日本消化器病学会四国支部例会, Jun. 2021.
162. Katsuki Miyazaki, Yu Saitou, Mayuko Shimizu, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Koichi Tsuneyama and Mitsuo Shimada :
小胞体ストレス応答に着目した非アルコール性脂肪肝炎の肝切除後肝再生/肝不全に関する研究,
第47回日本急性肝不全研究会, Jun. 2021.
163. Katsuki Miyazaki, Yu Saitou, Mayuko Shimizu, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada, Kazunori Tokuda, Koichi Tsuneyama and Mitsuo Shimada :
Endoplasmic reticulum stress response deficiency is a major cause of poor liver regeneration after hepatectomy in nonalcoholic steatohepatitis,
第33回日本肝胆膵外科学会学術集会, Jun. 2021.
164. Hiroki Teraoku, Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou and Katsuki Miyazaki :
Significance of frailty for eldery patients in HPB surgery,
第33回日本肝胆膵外科学会学術集会, Jun. 2021.
165. Shin-ichiro Yamada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Kazunori Tokuda, Hiroki Teraoku, Shohei Okikawa, Shoko Yamashita, Katsuki Miyazaki and Mitsuo Shimada :
Treatment strategy of multiple colorectal liver metastasis-Criteria for upfront surgery and Conversion Surgery-,
第33回日本肝胆膵外科学会学術集会, Jun. 2021.
166. Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada, Hiroki Teraoku, Maki Sugimoto and Mitsuo Shimada :
Intraoperative support with 3D holographic cholangiography in biliary surgery,
第33回日本肝胆膵外科学会学術集会, Jun. 2021.
167. Tetsuya Ikemoto, Kazunori Tokuda, Mitsuo Shimada, Yuji Morine, Satoru Imura, Yu Saitou, Shin-ichiro Yamada, Hiroki Teraoku and Katsuki Miyazaki :
Clinical application of auto-transplantation of generated insulin-producing cells from ADSC with Tokushima protocol,
第33回日本肝胆膵外科学会学術集会, Jun. 2021.
168. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Katsuki Miyazaki, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
肝門部領域胆管癌の切除成績と術後補助療法の意義,
第121回日本外科学会定期学術集会, Apr. 2021.
169. Tetsuya Ikemoto, Kazunori Tokuda and Mitsuo Shimada :
脂肪由来幹細胞から作製する消化器疾患に対する再生医療研究の展開,
第107回日本消化器病学会総会, Apr. 2021.
170. Kanto Yamasaki, Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, 杉本 真樹 and Mitsuo Shimada :
術中Real-time 3D胆管造影を併用した胆道手術,
第121回日本外科学会定期学術集会, Apr. 2021.
171. TAKAHASHI Akira, Yu Saitou, Tetsuya Ikemoto, Kazunori Tokuda, Katsuki Miyazaki, Shin-ichiro Yamada, Satoru Imura, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞ADSCからのSuper HLC (肝細胞様細胞)の創出,
第121回日本外科学会定期学術集会, Apr. 2021.
172. Kazunori Tokuda, Tetsuya Ikemoto, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Adipose derived stem cellから作製したInsulin producing cellの臨床応用に向けた保存方法に関する研究,
第121回日本外科学会定期学術集会, Apr. 2021.
173. Yu Saitou, Tetsu Tomonari, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Shin-ichiro Yamada, Tetsuji Takayama and Mitsuo Shimada :
進行肝細胞癌に対する集学的治療 - 分子標的治療薬使用によるConversion Surgery –,
第121回日本外科学会定期学術集会, Apr. 2021.
174. Katsuki Miyazaki, Yu Saitou, Mayuko Shimizu, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita, Koichi Tsuneyama and Mitsuo Shimada :

非アルコール性脂肪性肝疾患(NAFLD)における肝切除後肝再生機能不全に関する研究- 小胞体ストレス応答不全の観点より -, Apr. 2021.
175. Shoko Yamashita, Yuji Morine, Hiroki Ishibashi, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Yu Saitou, Shin-ichiro Yamada, Koichi Tsuneyama and Mitsuo Shimada :
膵・胆管合流異常における腫瘍微小環境と発癌に関する検討,
第121回日本外科学会定期学術集会, Apr. 2021.
176. Hiroki Teraoku, Gao Luping, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita and Katsuki Miyazaki :
肝細胞癌におけるSorafenib耐性獲得機序に関する検討,
第121回日本外科学会定期学術集会, Apr. 2021.
177. Shohei Okikawa, Yuji Morine, Kazunori Tokuda, Yu Saitou, Shin-ichiro Yamada, Shoko Yamashita, Katsuki Miyazaki, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
腫瘍微小環境におけるOsteopontinの意義,
第121回日本外科学会定期学術集会, Apr. 2021.
178. Shin-ichiro Yamada, 陳 術海, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita and Katsuki Miyazaki :
肝細胞癌微小環境におけるPAI-1発現の意義に関する検討,
Apr. 2021.
179. Tetsuya Ikemoto, Mitsuo Shimada, Kazunori Tokuda, Katsuki Miyazaki, Shin-ichiro Yamada, Yu Saitou, Satoru Imura and Yuji Morine :
再生医療を用いたインスリン枯渇状態の患者に対する自律的インスリン分泌細胞自己移植に関するAMED橋渡し研究,
第121回日本外科学会定期学術集会, Apr. 2021.
180. Kazunori Tokuda, Tetsuya Ikemoto, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞から作製したインスリン産生細胞の至適保存方法に関する研究,
第20回日本再生医療学会総会, Mar. 2021.
181. Yu Saitou, Tetsuya Ikemoto, Katsuki Miyazaki, Kazunori Tokuda, Shin-ichiro Yamada, Satoru Imura, Yuji Morine, Masato Miyake, Seiichi Oyadomari and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞から肝細胞様細胞の創出,
第20回日本再生医療学会総会, Mar. 2021.
182. Tetsuya Ikemoto, Takuya Tokunaga, Shohei Okikawa, Kazunori Tokuda, Shin-ichiro Yamada, Yu Saitou, Satoru Imura, Yuji Morine and Mitsuo Shimada :
脂肪由来幹細胞から分化誘導したSchwann-like cellの基礎的検討,
第20回日本再生医療学会総会, Mar. 2021.
183. Yuji Morine, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Shohei Okikawa, Katsuki Miyazaki, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
徳島大学の肝胆膵外科における若手教育-特に内視鏡手術に焦点をあてて-,
第33回日本内視鏡外科学会, Mar. 2021.
184. Yu Saitou, Tetsuya Ikemoto, Katsuki Miyazaki, Kazunori Tokuda, Shin-ichiro Yamada, Satoru Imura, Yuji Morine, Masato Miyake, Seiichi Oyadomari and Mitsuo Shimada :
ヒト脂肪由来間葉系幹細胞から肝細胞様細胞の創出- 肝不全・代謝性肝疾患に対する肝移植から細胞治療へ -,
第262回徳島医学会学術集会, Mar. 2021.
185. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa and Katsuki Miyazaki :
Significance of frailty for elderly patients in HPB surgery,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
186. Yu Saitou, Tetsuya Ikemoto, Yusuke Arakawa, Luping Gao, Shin-ichiro Yamada, Satoru Imura, Yuji Morine and Mitsuo Shimada :
Effective 3D culture of hepatocyte like cells human adipose derived mesenchymal stem cells,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
187. Yu Saitou, Tetsuya Ikemoto, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki, Maki Sugimoto and Mitsuo Shimada :
Intraoperative support with 3D holographic cholangiography and indocyanine green navigation,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
188. Katsuki Miyazaki, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Kazunori Tokuda, Masato Yoshikawa and Mitsuo Shimada :
The impact of frailty as a prognostic factor of colorectal liver metastasis,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
189. Yusuke Arakawa, Katsuki Miyazaki, Masato Yoshikawa, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
The value of CRP albumin ratio in patient with resectable pancreas cancer,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
190. Tetsuya Ikemoto, Kazunori Tokuda, Mitsuo Shimada, Yuji Morine, Satoru Imura, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Katsuki Miyazaki :
Basic research for aiming non-clinical PoC acquisition of insulin producing cells from ADSC with Tokushima protocol,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
191. Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki and Mitsuo Shimada :
Optimal surgical treatment including lymph nodes dissection and adjuvant chemotherapy for intrahepatic cholangiocarcinoma,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
192. Satoru Imura, Katsuki Miyazaki, Masato Yoshikawa, Kazunori Tokuda, Shin-ichiro Yamada, Yu Saitou, Yusuke Arakawa, Tetsuya Ikemoto, Yuji Morine and Mitsuo Shimada :
Standardization and stepwise training for safe laparoscopic hepatectomy,
第32回日本肝胆膵外科学会学術集会, Feb. 2021.
193. Shin-ichiro Yamada, 高 露泙, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yu Saitou, Kazunori Tokuda, Shohei Okikawa, Shoko Yamashita and Katsuki Miyazaki :
肝細胞癌におけるSorafenib耐性獲得機序に関する検討,
第23回日本肝がん分子標的治療研究会, Jan. 2021.
194. Yu Saitou, Tetsu Tomonari, Shin-ichiro Yamada, Satoru Imura, Tetsuya Ikemoto, Yuji Morine, Tetsuji Takayama and Mitsuo Shimada :
進行肝細胞癌に対する集学的治療-分子標的治療薬使用によるConversion Surgery-,
第23回日本肝がん分子標的治療研究会, Jan. 2021.
195. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa, Kazunori Tokuda and Katsuki Miyazaki :
肝胆膵領域悪性腫瘍におけるNrf2・VEGFに着目した腫瘍関連マクロファージ活性化についての検討,
第29回日本癌病態治療研究, Jan. 2021.
196. Yu Saitou, 高 露萍, Tetsuya Ikemoto, Yusuke Arakawa, Katsuki Miyazaki, Masato Yoshikawa, Shin-ichiro Yamada, Satoru Imura, Yuji Morine and Mitsuo Shimada :
GSK3 inhibitorsを用いた脂肪由来間葉系幹細胞から肝細胞様細胞への3次元分化誘導,
第38回日本肝移植学会学術集, Dec. 2020.
197. Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki, 杉本 真樹 and Mitsuo Shimada :
Hologramを用いた術中手術支援-術中Real-time3D胆管造影を併用した胆道手術-,
第45回日本外科系連合学会学術集会, Dec. 2020.
198. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa and Katsuki Miyazaki :
肝細胞癌に対する肝切除術におけるFrailtyの意義に関する検討,
第56回日本肝癌研究会, Dec. 2020.
199. Yu Saitou, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki and Mitsuo Shimada :
DAA治療後SVR症例は発癌Potentialが高く進行病期に関与する,
第56回日本肝癌研究会, Dec. 2020.
200. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Katsuki Miyazaki :
大腸癌同時性肝転移に対する治療戦略-肝切除適応基準とConversion Surgery-,
第56回日本肝癌研究会, Dec. 2020.
201. Katsuki Miyazaki, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou and Shin-ichiro Yamada :
肝内胆管癌予後規定因子としてのLymphocyte / CRP ratio (LCR)の意義,
第75回日本消化器外科学会総会, Dec. 2020.
202. Toshiaki Yoshimoto, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki, Yukako Takehara and Mitsuo Shimada :
膵切除周術期における栄養指標からみた人工膵臓の有用性,
第75回日本消化器外科学会総会, Dec. 2020.
203. Masato Yoshikawa, Yuji Morine, Shin-ichiro Yamada, Katsuki Miyazaki, Kazunori Tokuda, Yu Saitou, Yusuke Arakawa, Tetsuya Ikemoto, Satoru Imura and Mitsuo Shimada :
DWI-MRIのADC値を用いた転移性肝癌の切除後予後予測,抗癌剤効果予測に関する検討,
第75回日本消化器外科学会総会, Dec. 2020.
204. Kazunori Tokuda, Yuji Morine, Shin-ichiro Yamada, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa, Katsuki Miyazaki and Mitsuo Shimada :
転移性肝癌切除症例におけるFrailの重要性についての検討,
第75回日本消化器外科学会総会, Dec. 2020.
205. Shin-ichiro Yamada, Mitsuo Shimada, Yuji Morine, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Masato Yoshikawa and Katsuki Miyazaki :
胆嚢癌の悪性度評価におけるADCの有用性に関する検討,
第75回日本消化器外科学会総会, Dec. 2020.
206. Yu Saitou, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Yusuke Arakawa, Shin-ichiro Yamada, Masato Yoshikawa, Katsuki Miyazaki and Mitsuo Shimada :
DAA治療後SVR症例は発癌Potentialが高く進行病期に関与する,
第75回日本消化器外科学会総会, Dec. 2020.
207. Yusuke Arakawa, Katsuki Miyazaki, Masato Yoshikawa, Shin-ichiro Yamada, Yu Saitou, Tetsuya Ikemoto, Satoru Imura, Yuji Morine and Mitsuo Shimada :
当院の肝胆膵手術症例におけるSSIサーベイランスによる検討,
第75回日本消化器外科学会総会, Dec. 2020.
208. Tetsuya Ikemoto, Mitsuo Shimada, Yuji Morine, Satoru Imura, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Katsuki Miyazaki :
長期予後と患者QoLに着目した膵全摘症例の検討,
第75回日本消化器外科学会総会, Dec. 2020.
209. Yuji Morine, Mitsuo Shimada, Satoru Imura, Tetsuya Ikemoto, Yusuke Arakawa, Yu Saitou, Shin-ichiro Yamada, Masato Yoshikawa and Katsuki Miyazaki :
大腸癌同時性肝転移に対する治療戦略-肝切除適応基準とConversion Surgery-,
第75回日本消化器外科学会総会, Dec. 2020.